Lifecore Biomedical (LFCR) 10-Q 28 Mar 14 2014 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Feb. 23, 2014	Mar. 21, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'LANDEC CORP \CA\	'
Document Type	'10-Q	'
Current Fiscal Year End Date	'--05-25	'
Entity Common Stock, Shares Outstanding	'	26,780,273
Amendment Flag	'false	'
Entity Central Index Key	'0001005286	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Filer Category	'Accelerated Filer	'
Entity Well-known Seasoned Issuer	'No	'
Document Period End Date	23-Feb-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'

Consolidated_Balance_Sheets_Cu

Consolidated Balance Sheets (Current Period Unaudited) (USD $)	Feb. 23, 2014	26-May-13
In Thousands, unless otherwise specified
Current Assets:	'	'
Cash and cash equivalents	$12,987	$13,718
Marketable securities	'	1,545
Accounts receivable, less allowance for doubtful accounts of $357 and $583 at February 23, 2014 and May 26, 2013, respectively	41,041	36,072
Accounts receivable, related party	189	671
Income taxes receivable	4,214	5,103
Inventories, net	25,668	24,113
Deferred taxes	1,771	1,582
Prepaid expenses and other current assets	3,059	2,856
Total Current Assets	88,929	85,660
Investment in non-public company, non-fair value	793	793
Investment in non-public company, fair value	37,700	29,600
Property and equipment, net	70,973	65,811
Goodwill, net	49,620	49,620
Trademarks/tradenames, net	48,428	48,428
Customer relationships, net	8,942	9,606
Other assets	1,396	1,424
Total Assets	306,781	290,942
Current Liabilities:	'	'
Accounts payable	29,625	31,470
Accounts payable, related party	109	786
Accrued compensation	4,205	4,984
Other accrued liabilities	4,437	2,332
Deferred revenue	1,674	1,248
Lines of credit	'	4,000
Current portion of long-term debt	6,017	5,933
Total Current Liabilities	46,067	50,753
Long-term debt, less current portion	29,763	34,372
Deferred taxes	29,529	24,054
Other non-current liabilities	1,785	1,349
Total Liabilities	107,144	110,528
Total Stockholders’ Equity:	'	'
Common stock, $0.001 par value; 50,000,000 shares authorized; 26,780,273 and 26,402,247 shares issued and outstanding at February 23, 2014 and May 26, 2013, respectively	27	26
Additional paid-in capital	130,980	126,258
Retained earnings	67,012	52,409
Total Stockholders’ Equity	198,019	178,693
Non controlling interest	1,618	1,721
Total Equity	199,637	180,414
Total Liabilities and Stockholders’ Equity	$306,781	$290,942

Consolidated_Balance_Sheets_Cu1

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) (USD $)	Feb. 23, 2014	26-May-13
In Thousands, except Share data, unless otherwise specified
Allowance for doubtful accounts (in Dollars)	$357	$583
Common stock, par value (in Dollars per share)	$0.00	$0.00
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	26,780,273	26,402,247
Common stock, shares outstanding	26,780,273	26,402,247

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (Unaudited) (USD $)	3 Months Ended		9 Months Ended
Share data in Thousands, except Per Share data, unless otherwise specified	Feb. 23, 2014	Feb. 24, 2013	Feb. 23, 2014	Feb. 24, 2013
Revenues:	'	'	'	'
Product sales	$126,029,000	$117,584,000	$354,509,000	$332,977,000
Services revenue, related party	350,000	283,000	1,375,000	1,618,000
Total revenues	126,379,000	117,867,000	355,884,000	334,595,000
Cost of revenue:	'	'	'	'
Cost of product sales	105,961,000	100,090,000	308,281,000	283,461,000
Cost of services revenue	263,000	269,000	1,182,000	1,404,000
Total cost of revenue	106,224,000	100,359,000	309,463,000	284,865,000
Gross profit	20,155,000	17,508,000	46,421,000	49,730,000
Operating costs and expenses:	'	'	'	'
Research and development	1,723,000	2,325,000	5,568,000	6,642,000
Selling, general and administrative	8,700,000	8,524,000	25,969,000	26,266,000
Change in value of contingent consideration	'	'	'	-3,933,000
Total operating costs and expenses	10,423,000	10,849,000	31,537,000	28,975,000
Operating income	9,732,000	6,659,000	14,884,000	20,755,000
Dividend income	281,000	281,000	844,000	844,000
Interest income	78,000	46,000	183,000	104,000
Interest expense	-390,000	-487,000	-1,257,000	-1,526,000
Other income	400,000	1,047,000	8,100,000	6,288,000
Net income before taxes	10,101,000	7,546,000	22,754,000	26,465,000
Income tax expense	-3,679,000	-2,754,000	-8,028,000	-8,238,000
Consolidated net income	6,422,000	4,792,000	14,726,000	18,227,000
Non controlling interest	-22,000	-3,000	-123,000	-159,000
Net income and comprehensive income applicable to common stockholders	$6,400,000	$4,789,000	$14,603,000	$18,068,000
Basic net income per share (in Dollars per share)	$0.24	$0.19	$0.55	$0.70
Diluted net income per share (in Dollars per share)	$0.24	$0.18	$0.54	$0.68
Shares used in per share computation	'	'	'	'
Basic (in Shares)	26,697	25,839	26,574	25,752
Diluted (in Shares)	27,124	26,667	27,093	26,492

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Feb. 23, 2014	Feb. 24, 2013
Consolidated net income	$14,726,000	$18,227,000
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	5,364,000	5,527,000
Stock-based compensation expense	992,000	1,135,000
Tax benefit from stock-based compensation expense	-1,909,000	-2,743,000
Loss on disposal of property and equipment	330,000	180,000
Deferred taxes	5,286,000	4,230,000
Contingent Consideration	'	-3,933,000
Change in investment in non-public company (fair market value)	-8,100,000	-6,300,000
Changes in current assets and current liabilities:	'	'
Accounts receivable, net	-4,969,000	-5,316,000
Accounts receivable, related party	482,000	11,000
Income taxes receivable	2,798,000	2,790,000
Inventories, net	-1,555,000	-374,000
Prepaid expenses and other current assets	-203,000	-3,620,000
Accounts payable	-1,845,000	5,096,000
Accounts payable, related party	-677,000	-585,000
Accrued compensation	147,000	131,000
Other accrued liabilities	2,541,000	-2,564,000
Deferred revenue	426,000	1,583,000
Net cash provided by operating activities	13,834,000	13,475,000
Purchases of property and equipment	-10,192,000	-4,538,000
Purchase of marketable securities	-1,417,000	-5,239,000
Net cash used in investing activities	-8,647,000	-8,328,000
Proceeds from sale of common stock	2,147,000	1,385,000
Taxes paid by Company for stock swaps and RSUs	-1,252,000	-49,000
Tax benefit from stock-based compensation expense	1,909,000	2,743,000
Earn out payment from Lifecore acquisition	'	-9,650,000
Payments on long-term debt	-4,525,000	-4,476,000
Proceeds from lines of credit	3,500,000	'
Payments on lines of credit	-7,500,000	-7,666,000
Decrease in other assets	29,000	652,000
Payments to minority interest holders	-226,000	-320,000
Net cash used in financing activities	-5,918,000	-17,381,000
Net decrease in cash and cash equivalents	-731,000	-12,234,000
Cash and cash equivalents at beginning of period	13,718,000	22,177,000
Cash and cash equivalents at end of period	12,987,000	9,943,000
Earnout [Member]	'	'
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Contingent Consideration	'	-3,933,000
Change In Value [Member]	'	'
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Contingent Consideration	'	3,933,000
Marketable Maturities [Member]	'	'
Changes in current assets and current liabilities:	'	'
Proceeds from maturities of marketable securities	$2,962,000	$1,449,000

Note_1_Organization_Basis_of_P

Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies	9 Months Ended
	Feb. 23, 2014
Accounting Policies [Abstract]	'
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	'
	1.            Organization, Basis of Presentation and Summary of Significant Accounting Policies
	Organization
	Landec Corporation and its subsidiaries (“Landec” or the “Company”) design, develop, manufacture and sell differentiated products for food and biomaterials markets and license technology applications to partners. The Company has two proprietary polymer technology platforms: 1) Intelimer® polymers, and 2) hyaluronan (“HA”) biopolymers. The Company sells specialty packaged branded Eat Smart® and GreenLine® and private label fresh-cut vegetables and whole produce to retailers, club stores and foodservice operators, primarily in the United States, Canada and Asia through its Apio, Inc. (“Apio”) subsidiary and sells HA-based biomaterials through its Lifecore Biomedical, Inc. (“Lifecore”) subsidiary. The Company’s HA biopolymers are proprietary in that they are specially formulated for specific customers to meet strict regulatory requirements. The Company’s polymer technologies, along with its customer relationships and trade names, are the foundation, and a key differentiating advantage upon which Landec has built its business.
	Basis of Presentation
	The accompanying unaudited consolidated financial statements of Landec have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring accruals) have been made which are necessary to present fairly the financial position at February 23, 2014 and the results of operations and cash flows for all periods presented. Although Landec believes that the disclosures in these financial statements are adequate to make the information presented not misleading, certain information normally included in financial statements and related footnotes prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted in accordance with the rules and regulations of the Securities and Exchange Commission. The accompanying financial data should be reviewed in conjunction with the audited financial statements and accompanying notes included in Landec's Annual Report on Form 10-K for the fiscal year ended May 26, 2013.
	The results of operations for the nine months ended February 23, 2014 are not necessarily indicative of the results that may be expected for an entire fiscal year because there is some seasonality in Apio’s food business, particularly, Apio’s Food Export business and the order patterns of Lifecore’s customers which may lead to significant fluctuations in Landec’s quarterly results of operations.
	Basis of Consolidation
	The consolidated financial statements are presented on the accrual basis of accounting in accordance with U.S. generally accepted accounting principles and include the accounts of Landec Corporation and its subsidiaries, Apio and Lifecore. All material inter-company transactions and balances have been eliminated.
	Arrangements that are not controlled through voting or similar rights are reviewed under the guidance for variable interest entities (“VIEs”). A company is required to consolidate the assets, liabilities and operations of a VIE if it is determined to be the primary beneficiary of the VIE.
	An entity is a VIE and subject to consolidation, if by design: a) the total equity investment at risk is not sufficient to permit the entity to finance its activities without additional subordinated financial support provided by any parties, including equity holders or b) as a group the holders of the equity investment at risk lack any one of the following three characteristics: (i) the power, through voting rights or similar rights to direct the activities of an entity that most significantly impact the entity’s economic performance, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity. The Company reviewed the consolidation guidance and concluded that its partnership interest in Apio Cooling and its equity investments in non-public companies are not VIEs.
	Use of Estimates
	The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make certain estimates and judgments that affect the amounts reported in the financial statements and accompanying notes. The accounting estimates that require management’s most significant and subjective judgments include revenue recognition; sales returns and allowances; recognition and measurement of current and deferred income tax assets and liabilities; the assessment of recoverability of long-lived assets; the valuation of intangible assets and inventory; the valuation of investments; the self-insurance liability; and the valuation and recognition of stock-based compensation.
	These estimates involve the consideration of complex factors and require management to make judgments. The analysis of historical and future trends can require extended periods of time to resolve and is subject to change from period to period. The actual results may differ from management’s estimates.
	Cash and Cash Equivalents
	The Company records all highly liquid securities with three months or less from date of purchase to maturity as cash equivalents. Cash equivalents consist mainly of certificate of deposits (CDs), money market funds and U.S. Treasuries. The market value of cash equivalents approximates their historical cost given their short-term nature.
	Marketable Securities
	Short-term marketable securities consist of CDs that are FDIC insured and single A or better rated corporate and municipal bonds with original maturities of more than three months at the date of purchase regardless of the maturity date. The Company classifies all debt securities with readily determined market values as “available for sale.” The aggregate amount of CDs included in marketable securities at February 23, 2014 and May 26, 2013 was zero and $701,000, respectively. The contractual maturities of the Company’s marketable securities that are due in less than one year represented zero and $1.3 million of its marketable securities as of February 23, 2014 and May 26, 2013, respectively. The contractual maturities of the Company’s marketable securities that are due in one to two years represented zero and $251,000 of its marketable securities as of February 23, 2014 and May 26, 2013, respectively. Investments in marketable securities are carried at fair market value with unrealized gains and losses reported as other income. The cost of debt securities is adjusted for amortization of premiums and discounts to maturity. This amortization is recorded to interest income. Realized gains and losses on the sale of available-for-sale securities are also recorded to interest income. During the three and nine months ended February 23, 2014 and February 24, 2013, the Company did not sell any marketable securities. The cost of securities sold is based on the specific identification method.
	Financial Instruments
	The Company’s financial instruments are primarily composed of marketable securities, commercial-term trade payables, grower advances, notes receivable and debt instruments. For short-term instruments, the historical carrying amount approximates the fair value of the instrument. The fair value of long-term debt and lines of credit approximates their carrying value. Fair values for long-term financial instruments not readily marketable are estimated based upon discounted future cash flows at prevailing market interest rates. Based on these assumptions, management believes the fair market values of the Company’s financial instruments are not materially different from their recorded amounts as of February 23, 2014 and May 26, 2013.
	Investments in Non-Public Companies
	The Company’s investment in Aesthetic Sciences Corporation (“Aesthetic Sciences”), which is reported as an investment in non-public company, non-fair value, in the accompanying Consolidated Balance Sheets, is carried at cost and adjusted for impairment losses. Since there is no readily available market value information, the Company periodically reviews this investment to determine if any other than temporary declines in value have occurred based on the financial stability and viability of Aesthetic Sciences.
	On February 15, 2011, the Company made an investment in Windset Holdings 2010 Ltd., a Canadian corporation (“Windset”), which is reported as an investment in non-public company, fair value, in the accompanying Consolidated Balance Sheets as of February 23, 2014 and May 26, 2013. The Company has elected to account for its investment in Windset under the fair value option (see Note 4).
	Change in Depreciable Lives of Property and Equipment
	In accordance with its policy, the Company reviews the estimated useful lives of its fixed assets on an ongoing basis. This review primarily indicated that the actual lives of certain buildings and machinery and equipment at its processing facilities were longer than the estimated useful lives used for depreciation purposes in the Company’s financial statements. As a result, effective November 25, 2013, the Company changed its estimates of the useful lives of its buildings and machinery and equipment to better reflect the estimated periods during which these assets will remain in service. The Company’s buildings that previously averaged 29 years were increased to an average of 35 years. The Company’s machinery and equipment that previously averaged 7 years were increased to an average of 11 years. The effect of this change in estimate for the three months ended February 23, 2014 was to decrease depreciation expense by $438,000, increase net income by $284,000, and increase basic and diluted earnings per share by $0.01.
	Intangible Assets
	The Company’s intangible assets are comprised of customer relationships with a finite estimated useful life of twelve to thirteen years and trademarks, trade names and goodwill with indefinite lives.
	Finite-lived intangible assets are reviewed for possible impairment whenever events or changes in circumstances occur that indicate that the carrying amount of an asset (or asset group) may not be recoverable.  Indefinite lived intangible assets are reviewed for impairment at least annually, in accordance with accounting guidance. For non-goodwill indefinite-lived intangible assets, the Company performs a qualitative analysis in accordance with ASC 350-30-35. For goodwill, the Company performs a quantitative analysis in accordance with ASC 350-20-35.
	During the fiscal quarter ended February 23, 2014, the Company voluntarily changed the date of its annual goodwill and indefinite-lived intangible assets impairment testing from the last day of the fiscal month in July to the first day of the fiscal fourth quarter. This voluntary change is preferable under the circumstances as it provides the Company with additional time to complete its annual goodwill and indefinite-lived intangible asset impairment testing in advance of its year-end reporting and results in better alignment with the Company’s strategic planning and forecasting process. The voluntary change in accounting principle related to the annual testing date will not delay, accelerate, or avoid an impairment charge. This change is not applied retrospectively as it is impracticable to do so because retrospective application would require application of significant estimates and assumptions with the use of hindsight. Accordingly, the change will be applied prospectively.
	Partial Self-Insurance on Employee Health Plan
	The Company provides health insurance benefits to eligible employees under a self-insured plan whereby the Company pays actual medical claims subject to certain stop loss limits. The Company records self-insurance liabilities based on actual claims filed and an estimate of those claims incurred but not reported. Any projection of losses concerning the Company's liability is subject to a high degree of variability. Among the causes of this variability are unpredictable external factors such as inflation rates, changes in severity, benefit level changes, medical costs, and claims settlement patterns. This self-insurance liability is included in accrued liabilities and represents management's best estimate of the amounts that have not been paid as of February 23, 2014. It is reasonably possible that the expense the Company ultimately incurs could differ and adjustments to future reserves may be necessary.
	Fair Value Measurements
	The Company uses fair value measurement accounting for financial assets and liabilities and for financial instruments and certain other items measured at fair value. The Company has elected the fair value option for its investment in a non-public company (see Note 4). The Company has not elected the fair value option for any of its other eligible financial assets or liabilities.
	The accounting guidance established a three-tier hierarchy for fair value measurements, which prioritizes the inputs used in measuring fair value as follows:
	Level 1 – observable inputs such as quoted prices for identical instruments in active markets.
	Level 2 – inputs other than quoted prices in active markets that are observable either directly or indirectly through corroboration with observable market data.
	Level 3 – unobservable inputs in which there is little or no market data, which would require the Company to develop its own assumptions.
	As of February 23, 2014, the Company held certain assets and liabilities that are required to be measured at fair value on a recurring basis, including marketable securities, interest rate swap and a minority interest investment in Windset.
	The fair value of the Company’s marketable securities is determined based on observable inputs that are readily available in public markets or can be derived from information available in publicly quoted markets. Therefore, the Company has categorized its marketable securities as a Level 1 measurement.
	The fair value of the Company’s interest rate swap is determined based on model inputs that can be observed in a liquid market, including yield curves, and is categorized as a Level 2 measurement.
	The Company has elected the fair value option of accounting for its investment in Windset. The calculation of fair value utilizes significant unobservable inputs in the discounted cash flow models, including projected cash flows, growth rates and discount rates. As a result, the Company’s investment in Windset is considered to be a Level 3 measurement investment. The change in the fair market value of the Company’s investment in Windset for the three and nine months ended February 23, 2014 was due to the Company’s 20.1% minority interest in the change in the fair market value of Windset during those periods. In determining the fair value of the investment in Windset, the Company utilizes the following significant unobservable inputs in the discounted cash flow models:
		At February 23, 2014			At May 26, 2013
	Annual consolidated revenue growth rates		4%		3%	to	9%
	Annual consolidated expense growth rates	3%	to	4%	3%	to	8%
	Consolidated income tax rate		15%			15%
	Consolidated discount rates	16%	to	22%	18%	to	28%
	The revenue growth, expense growth and income tax rate assumptions, consider the Company's best estimate of the trends in those items over the discount period. The discount rate assumption takes into account the risk-free rate of return, the market equity risk premium and the company’s specific risk premium (collectively the “Discount rate”) and then applies an additional discount for lack of marketability of the underlying securities. The discounted cash flow valuation model used by the Company has the following sensitivity to changes in inputs and assumptions (in thousands):
			Impact on value of Windset investment as of February23, 2014
	10% increase in annual revenue growth rates		$	2,900
	10% increase in annual expense growth rates		$	(2,700	)
	10% increase in income tax rates		$	(100	)
	10% increase in discount rate		$	(1,600	)
	Imprecision in estimating unobservable market inputs can affect the amount of gain or loss recorded for a particular position. The use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.
	The following table summarizes the fair value of the Company’s assets and liabilities that are measured at fair value on a recurring basis, as of February 23, 2014 and May 26, 2013 (in thousands):
			Fair Value at February 23, 2014								Fair Value at May 26, 2013
	Assets:		Level 1				Level 2		Level 3		Level 1		Level 2		Level 3
	Marketable securities		$	-			$	-	$	-	$	1,545	$	-	$	-
	Investment in private company			-				-		37,700		-		-		29,600
	Total		$	-			$	-	$	37,700	$	1,545	$	-	$	29,600
	Liabilities:
	Interest rate swap		$	-			$	67	$	-	$	-	$	163	$	-
	Total		$	-			$	67	$	-	$	-	$	163	$	-
	Revenue Recognition
	The Company recognizes revenue when the earnings process is complete, as evidenced by an agreement with the customer, transfer of title, and acceptance, if applicable, as well as fixed pricing and probable collectability. The Company records pricing allowances, including discounts based on arrangements with customers, as a reduction to both accounts receivable and net revenue.
When a sales arrangement contains multiple elements, the Company allocates revenue to each element based on a selling price hierarchy. The relative selling price for a deliverable is based on its vendor-specific objective evidence (VSOE), if available, third-party evidence (TPE), if VSOE is not available, or estimated selling price, if neither VSOE nor TPE is available. The Company then recognizes revenue on each deliverable in accordance with its policies for product and service revenue recognition. The Company is not typically able to determine VSOE or TPE, and therefore, uses estimated selling prices to allocate revenue between the elements of the arrangement.
The Company limits the amount of revenue recognition for delivered elements to the amount that is not contingent on the future delivery of products or services or future performance obligations or subject to customer-specific cancellation rights. The Company evaluates each deliverable in an arrangement to determine whether they represent separate units of accounting. A deliverable constitutes a separate unit of accounting when it has stand-alone value, and for an arrangement that includes a general right of return relative to the delivered products or services, delivery or performance of the undelivered product or service is considered probable and is substantially controlled by the Company. The Company considers a deliverable to have stand-alone value if the product or service is sold separately by the Company or another vendor or could be resold by the customer. Further, the revenue arrangements generally do not include a general right of return relative to the delivered products. Where the aforementioned criteria for a separate unit of accounting are not met, the deliverable is combined with the undelivered element(s) and treated as a single unit of accounting for the purposes of allocation of the arrangement consideration and revenue recognition. The Company allocates the total arrangement consideration to each separable element of an arrangement based upon the relative selling price of each element. Allocation of the consideration is determined at arrangement inception on the basis of each unit’s relative selling price. In instances where the Company has not established fair value for any undelivered element, revenue for all elements is deferred until delivery of the final element is completed and all recognition criteria are met.
Recently Adopted Accounting Standards
Unrecognized Tax Benefit
In July 2013, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (a consensus of the FASB Emerging Issues Task Force) ("ASU 2013-11"), which provides that a liability related to an unrecognized tax benefit would be offset against a deferred tax asset for a net operating loss carryforward, a similar tax loss or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed. In situations in which a net operating loss carryforward, a similar tax loss or a tax credit carryforward is not available at the reporting date under the tax law of the jurisdiction or the tax law of the jurisdiction does not require, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit will be presented in the financial statements as a liability and will not be combined with deferred tax assets. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Retrospective application is permitted. ASU 2013-11 is effective for fiscal years and interim periods beginning after December 15, 2013, with early adoption permitted. The Company early adopted in the first quarter of fiscal year 2014 this standard and such adoption did not have a significant impact on the Company’s financial position or results of operations.

Note_2_Acquisitions_of_GreenLi

Note 2 - Acquisitions of GreenLine Holding Company	9 Months Ended
	Feb. 23, 2014
Business Combinations [Abstract]	'
Business Combination Disclosure [Text Block]	'
	2.             Acquisition of GreenLine Holding Company
	On April 23, 2012 (the “GreenLine Acquisition Date”), Apio acquired all of the outstanding equity of GreenLine Holding Company (“GreenLine”) pursuant to a Stock Purchase Agreement (the “GreenLine Purchase Agreement”) in order to expand its product offerings and enter into new markets such as foodservice. GreenLine, headquartered in Bowling Green, Ohio, was a privately-held company and is the leading processor and marketer of value-added, fresh-cut green beans in North America. GreenLine has four processing plants one each in Ohio, Pennsylvania, Florida and California and distribution centers in New York and South Carolina.
	The acquisition date fair value of the total consideration transferred was $66.8 million, which consisted of the following (in thousands):
	Cash	$	62,900
	Contingent consideration		3,933
	Total	$	66,833
	The assets and liabilities of GreenLine were recorded at their respective estimated fair values as of the date of the acquisition using generally accepted accounting principles for business combinations. The excess of the purchase price over the fair value of the net identifiable assets acquired has been allocated to goodwill. Goodwill represents a substantial portion of the acquisition proceeds because of the workforce in-place at acquisition and because of GreenLine’s long history and future prospects. Management believes that there is further growth potential by extending GreenLine’s product lines into new channels, such as club stores.
	The following table summarizes the estimated fair values of GreenLine’s assets acquired and liabilities assumed and related deferred income taxes, effective April 23, 2012, the date the Company obtained control of GreenLine (in thousands).
	Accounts receivable, net	$	7,057
	Inventories, net		1,409
	Property and equipment		11,669
	Other tangible assets		306
	Intangible assets		43,500
	Total identifiable assets acquired		63,941
	Accounts payable and other liabilities		(8,391	)
	Deferred taxes		(1,875	)
	Total liabilities assumed		(10,266	)
	Net identifiable assets acquired		53,675
	Goodwill		13,158
	Net assets acquired	$	66,833
	The Company used a combination of the market and cost approaches to estimate the fair values of the GreenLine assets acquired and liabilities assumed.
	Intangible Assets
	The fair value of indefinite and finite-lived intangible assets was determined using a discounted cash flow (DCF) model, under an income valuation methodology, based on management’s five-year projections of revenues, gross profits and operating profits by fiscal year and assumed a 40% effective tax rate for each year. Management took into account the historical trends of GreenLine and the industry categories in which GreenLine operates along with inflationary factors, current economic conditions, new product introductions, cost of sales, operating expenses, capital requirements and other relevant data when developing its projection. The Company believes that the level and timing of cash flows appropriately reflect market participant assumptions. The projected cash flows from these intangibles were based on key assumptions such as estimates of revenues and operating profits related to the intangibles over their respective forecast periods. The resultant cash flows were then discounted using a rate the Company believes is appropriate given the inherent risks associated with each intangible asset and reflect market participant assumptions.
	The Company identified two intangible assets in connection with the GreenLine acquisition: tradenames and trademarks valued at $36.0 million, which are considered to be indefinite life assets and therefore, will not be amortized; and customer base valued at $7.5 million with a thirteen year useful life. The tradename/trademark intangible asset was valued using the relief from royalty valuation method and the customer relationship intangible asset was valued using the distributor method.
	Goodwill
	The excess of the consideration transferred over the fair values assigned to the assets acquired and liabilities assumed was $13.2 million on the closing date, which represents the goodwill amount resulting from the acquisition which can be attributable to GreenLine’s long history, future prospects and the expected operating synergies from combining GreenLine with Apio’s fresh-cut, value-added vegetable business. None of the goodwill is expected to be deductible for income tax purposes. The Company tests goodwill for impairment on an annual basis or sooner, if indicators of impairment are present.

Note_3_Sale_of_Landec_Ag

Note 3 - Sale of Landec Ag	9 Months Ended
	Feb. 23, 2014
Disclosure Text Block Supplement [Abstract]	'
Mergers, Acquisitions and Dispositions Disclosures [Text Block]	'
	3.             Sale of Landec Ag
	On June 24, 2012, Landec entered into a stock purchase agreement and two licensing agreements (see Note 5) with INCOTEC® Coating and Seed Technology Companies (“INCOTEC”), a leading provider of seed and coating technology products and services to the seed industry.
	In the stock purchase agreement, Landec sold its equity interest in its seed subsidiary, Landec Ag LLC, to INCOTEC for $600,000, which resulted in a gain of $400,000. Under accounting guidance, because the stock purchase agreement was entered into at the same time the license agreements were consummated (a multiple element agreement), a portion of the gain, or $300,000, has been deferred and will be recognized as revenue monthly from the sale date over the seven year life of the Pollinator Plus® license agreement (see Note 5). The remaining $100,000 of the gain was recognized during the first quarter of fiscal year 2013.

Note_4_Investments_in_Nonpubli

Note 4 - Investments in Non-public Companies	9 Months Ended
	Feb. 23, 2014
Investment Holdings [Abstract]	'
Investment Holdings [Text Block]	'
	4.            Investments in non-public companies
	In December 2005, Landec entered into a licensing agreement with Aesthetic Sciences for the exclusive rights to use Landec's Intelimer® materials technology for the development of dermal fillers worldwide under the agreement. The Company received shares of preferred stock in exchange for the license with a valuation of $1.8 million. Aesthetic Sciences sold the rights to its Smartfil™ Injector System on July 16, 2010. Landec has evaluated its investment in Aesthetic Sciences for impairment, utilizing a discounted cash flow analysis under the terms of the purchase agreement. Based on the terms of the sale, the Company determined that its investment was other than temporarily impaired and therefore, recorded an impairment charge of $1.0 million as of May 30, 2010. The Company’s carrying value of its investment in Aesthetic Sciences is $793,000 as of February 23, 2014 and May 26, 2013. No additional impairment has been determined for the Company’s investment in Aesthetic Sciences.
	On February 15, 2011, Apio entered into a share purchase agreement (the “Windset Purchase Agreement”) with Windset. Pursuant to the Windset Purchase Agreement, Apio purchased 150,000 senior preferred shares for $15 million and 201 common shares for $201 that were issued by Windset (the “Purchased Shares”). The Company’s common shares represent a 20.1% interest in Windset. The non-voting senior preferred shares yield a cash dividend of 7.5% annually. The dividend is payable within 90 days of each anniversary of the execution of the Windset Purchase Agreement and the first two dividend payments of $1.1 million were made in May 2012 and May 2013. The Windset Purchase Agreement includes a put and call option, which can be exercised on the sixth anniversary of the Windset Purchase Agreement whereby Apio can exercise the put to sell its Purchased Shares to Windset, or Windset can exercise the call to purchase the Purchased Shares from Apio, in either case, at a price equal to 20.1% of the appreciation in the fair market value of Windset from the date of the Company’s investment through the put and call date, plus the purchase price of the Purchased Shares. Under the terms of the arrangement with Windset, the Company is entitled to designate one of five members on the Board of Directors of Windset.
	The investment in Windset does not qualify for equity method accounting as the investment does not meet the criteria of in-substance common stock due to returns through the annual dividend on the non-voting senior preferred shares that are not available to the common stock holders. As the put and call options require the Purchased Shares to be put or called in equal proportions, the Company has deemed that the investment, in substance, should be treated as a single security for purposes of accounting. The Company has adopted fair value option in the accounting for its investment in Windset effective on the acquisition date. The fair value of the Company’s investment in Windset utilizes significant unobservable inputs in the discounted cash flow models, including projected cash flows, revenue/expense growth rates and discount rates (see Note 1) and is therefore considered a Level 3 investment for fair value measurement purposes. The Company believes that reporting its investment at fair value provides its investors with useful information on the performance of the Company’s investment and the anticipated appreciation in value as Windset expands its business.
	The fair value of the Company’s investment in Windset was determined utilizing a discounted cash flow model based on projections developed by Windset, and considers the put and call conversion options. These features impact the duration of the cash flow utilized to derive the estimated fair value of the investment. Assumptions included in the discounted cash flow model will be evaluated quarterly based on Windset’s actual and projected operating results to determine the change in fair value.
	During the three and nine months ended February 23, 2014 and February 24, 2013, the Company recorded $281,000 and $844,000, respectively, in dividend income. The increase in the fair market value of the Company’s investment in Windset for the three months ended February 23, 2014 and February 24, 2013 was $400,000 and $1.0 million, respectively, and is included in other income in the Consolidated Statements of Comprehensive Income. The increase in the fair market value of the Company’s investment in Windset for the nine months ended February 23, 2014 and February 24, 2013 was $8.1 million and $6.3 million, respectively, and is included in other income in the Consolidated Statements of Comprehensive Income.
	The Company also entered into an exclusive license agreement with Windset, which was executed in June 2010, prior to contemplation of Apio’s investment in Windset (see Note 5).

Note_5_Collaborative_Agreement

Note 5 - Collaborative Agreements	9 Months Ended
	Feb. 23, 2014
License Agreements [Abstract]	'
License Agreements [Text Block]	'
	5.            Collaborative Agreements
	INCOTEC
	In connection with the sale of Landec Ag to INCOTEC on June 24, 2012 (see Note 3), Landec entered into a seven-year exclusive technology license and polymer supply agreement with INCOTEC for the use of Landec’s Intellicoat® polymer seed coating technology for male inbred corn which is sold under the Pollinator Plus label. This license does not include the use of Intellicoat for the controlled release of an active ingredient for agricultural applications which was retained by Landec. Landec will be the exclusive supplier of Pollinator Plus polymer to INCOTEC during the term of the license agreement. Landec will receive a royalty equal to 20% of the revenues realized by INCOTEC from the sale of or sublicense of Pollinator Plus coatings during the first four years of the agreement and 10% for the last three years of the agreement.
	On June 24, 2012, Landec also entered into a five-year exclusive technology license and polymer supply agreement with INCOTEC for the joint development of new polymer and unique coatings for use in seed treatment formulations. In this agreement, Landec will receive a value share which will be mutually agreed to by both parties prior to each application being developed.
	Air Products
	In March 2006, Landec entered into an exclusive license and research and development agreement with Air Products and Chemicals, Inc. (“Air Products”). In accordance with the agreement, Landec receives 40% of the direct profit generated from the sale of products by Air Products occurring after April 1, 2007, that incorporate Landec’s Intelimer materials.
	Chiquita
	The agreement with Chiquita has been renewed through December 2016 and requires Chiquita to pay annual gross profit minimums to Landec in order for Chiquita to maintain its exclusive license for bananas. Under the terms of the agreement, Chiquita must notify Landec before December 1st of each year whether it is going to maintain its exclusive license. Landec was notified in November 2012 of Chiquita’s desire to not maintain its exclusive license. As a result, the agreement has reverted to a non-exclusive agreement in which Chiquita will pay the Company for membranes purchased and the Company is now entitled to sell its BreatheWay packaging technology for bananas to others.
	Windset
	In June 2010, Apio entered into an exclusive license agreement with Windset to allow for the use of Landec’s proprietary breathable packaging to extend the shelf life of greenhouse grown cucumbers, peppers and tomatoes (“Exclusive Products”). In accordance with the agreement, Apio received and recorded a one-time upfront research and development fee of $100,000 and will receive license fees equal to 3% of net revenue of the Exclusive Products utilizing the proprietary breathable packaging technology, with or without the BreatheWay® trademark. The ongoing license fees are subject to annual minimums of $150,000 for each of the three types of exclusive product as each is added to the agreement. As of February 23, 2014, two products have been added to the agreement.

Note_6_StockBased_Compensation

Note 6 - Stock-Based Compensation	9 Months Ended
	Feb. 23, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	'
	6.            Stock-Based Compensation
	In the three and nine months ended February 23, 2014, the Company recognized stock-based compensation expense of $353,000 and $1.0 million, respectively, which included $222,000 and $576,000 for restricted stock unit awards and $131,000 and $416,000 for stock option grants, respectively.
	In the three and nine months ended February 24, 2013, the Company recognized stock-based compensation expense of $464,000 and $1.1 million, respectively, which included $230,000 and $528,000 for restricted stock unit awards and $234,000 and $607,000 for stock option grants, respectively.
	The following table summarizes the stock-based compensation by income statement line item:
		Three Months Ended February 23, 2014		Three Months Ended		Nine Months Ended		Nine Months Ended
				24-Feb-13		23-Feb-14		24-Feb-13
	Research and development	$	14,000	$	251,000	$	28,000	$	465,000
	Sales, general and administrative	$	339,000	$	213,000	$	964,000	$	670,000
	Total stock-based compensation	$	353,000	$	464,000	$	992,000	$	1,135,000
	As of February 23, 2014, there was $2.4 million of total unrecognized compensation expense related to unvested equity compensation awards granted under the Landec equity plans. Total expense is expected to be recognized over the weighted-average period of 2.1 years for stock options and 2.0 years for restricted stock unit awards.

Note_7_Diluted_Net_Income_Per_

Note 7 - Diluted Net Income Per Share	9 Months Ended
	Feb. 23, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share [Text Block]	'
	7. Diluted Net Income Per Share
	The following table sets forth the computation of diluted net income per share (in thousands, except per share amounts):
		Three Months Ended		Three Months Ended		Nine Months Ended		Nine Months Ended
		February 23,		February 24,		February 23,		February 24,
		2014		2013		2014		2013
	Numerator:
	Net income and comprehensive income applicable to common stockholders	$	6,400	$	4,789	$	14,603	$	18,068
	Denominator:
	Weighted average shares for basic net income per share		26,697		25,839		26,574		25,752
	Effect of dilutive securities:
	Stock options and restricted stock units		427		828		519		740
	Weighted average shares for diluted net income per share		27,124		26,667		27,093		26,492
	Diluted net income per share	$	0.24	$	0.18	$	0.54	$	0.68
	For the three months ended February 23, 2014 and February 24, 2013, the computation of the diluted net income per share excludes the impact of options to purchase 342,500 shares and 95,527 shares of Common Stock, respectively, as such impacts would be antidilutive for these periods.
	For the nine months ended February 23, 2014 and February 24, 2013, the computation of the diluted net income per share excludes the impact of options to purchase 332,037 shares and 88,128 shares of Common Stock, respectively, as such impacts would be antidilutive for these periods.

Note_8_Income_Taxes

Note 8 - Income Taxes	9 Months Ended
	Feb. 23, 2014
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	8.             Income Taxes
	The provision for income taxes for the three and nine months ended February 23, 2014 was $3.7 million and $8.0 million, respectively. The effective tax rate for the nine months ended February 23, 2014 was 35% compared to 31% for the same periods in fiscal year 2013. Although the effective tax rate for the nine months ended February 23, 2014 was the same as the statutory federal income tax rate of 35% there were several offsetting factors, including state taxes, domestic manufacturing deductions, non-deductible stock-based compensation expense and the benefit of federal and state research and development credits.
	As of February 23, 2014 and May 26, 2013, the Company had unrecognized tax benefits of approximately $1.0 million.  Included in the balance of unrecognized tax benefits as of February 23, 2014 and May 26, 2013 is approximately $827,000 and $807,000, respectively, of tax benefits that, if recognized, would result in an adjustment to the Company’s effective tax rate.  The Company does not expect its unrecognized tax benefits to change significantly within the next twelve months.
	The Company classifies interest and penalties related to uncertain tax positions as a component of its provision for income taxes.  The Company has accrued an insignificant amount of interest and penalties relating to the income tax on the unrecognized tax benefits as of February 23, 2014 and May 26, 2013.
	Due to tax attribute carryforwards, the Company is subject to examination for tax years 1997 forward for U.S. tax purposes. The Company is also subject to examination in various state jurisdictions for tax years 1998 forward, none of which were individually material.

Note_9_Inventories

Note 9 - Inventories	9 Months Ended
	Feb. 23, 2014
Inventory Disclosure [Abstract]	'
Inventory Disclosure [Text Block]	'
	9.            Inventories
	Inventories are stated at the lower of cost (first-in, first-out method) or market and consisted of the following (in thousands):
			23-Feb-14		26-May-13
	Finished goods	$	12,358	$	11,297
	Raw materials		10,590		9,290
	Work in progress		2,720		3,526
	Total	$	25,668	$	24,113

Note_10_Debt

Note 10 - Debt	9 Months Ended
	Feb. 23, 2014
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	10.          Debt
	Long-term debt consists of the following:
			23-Feb-14			26-May-13
			(in thousands)			(in thousands)
	Real estate loan agreement with General Electric Capital Corporation (“GE Capital”); due in monthly principal and interest payments of $133,060 through May 1, 2022 with interest based on a fixed rate of 4.02% per annum		$	16,373		$	17,065
	Capital equipment loan with GE Capital; due in monthly principal and interest payments of $175,356 through May 1, 2019 with interest based on a fixed rate of 4.39% per annum			9,852			11,080
	Term note with BMO Harris Bank N.A. (“BMO Harris”); due in monthly payments of $250,000 through May 23, 2016 with interest payable monthly at LIBOR plus 2% per annum			6,750			9,000
	Industrial revenue bonds (“IRBs”) issued by Lifecore; due in annual payments through 2020 with interest at a variable rate set weekly by the bond remarketing agent (0.23% and 0.38% at February 23, 2014 and May 26, 2013, respectively)			2,805			3,160
	Total			35,780			40,305
	Less current portion			(6,017	)		(5,933	)
	Long-term portion		$	29,763		$	34,372
	In addition to entering into the GE Capital real estate and equipment loans mentioned above, on April 23, 2012 in connection with the acquisition of GreenLine, Apio also entered into a five-year, $25.0 million asset-based working capital revolving line of credit, with an interest rate of LIBOR plus 2%, with availability based on the combination of the eligible accounts receivable and eligible inventory (availability was $19.2 million at February 23, 2014). Apio’s revolving line of credit has an unused fee of 0.375% per annum. At February 23, 2014 and May 26, 2013, Apio had zero and $4.0 million, respectively, outstanding under its revolving line of credit.
	The GE Capital real estate, equipment and line of credit agreements (collectively the “GE Debt Agreements”) are secured by liens on all of the property of Apio and its subsidiaries. The GE Debt Agreements contain customary events of default under which obligations could be accelerated or increased. The GE Debt Agreements are guaranteed by Landec and Landec has pledged its equity interest in Apio as collateral under the agreements. The GE Debt Agreements contain customary covenants, such as limitations on the ability to (1) incur indebtedness or grant liens or negative pledges on Apio’s assets; (2) make loans or other investments; (3) pay dividends, sell stock or repurchase stock or other securities; (4) sell assets; (5) engage in mergers; (6) enter into sale and leaseback transactions; and (7) make changes in Apio’s corporate structure. In addition, Apio must maintain a minimum fixed charge coverage ratio of not less than 1.10 to 1.0. Apio was in compliance with all financial covenants as of February 23, 2014. Unamortized loan origination fees for the GE Debt Agreements were $1.0 million and $1.2 million at February 23, 2014 and May 26, 2013, respectively, and are included in other assets in the Consolidated Balance Sheets. Amortization of loan origination fees recorded to interest expense for the three months ended February 23, 2014 and February 24, 2013 were $47,000 and $45,000, respectively. Amortization of loan origination fees recorded to interest expense for the nine months ended February 23, 2014 and February 24, 2013 were $140,000 and $136,000, respectively.
	On May 23, 2012, Lifecore entered into two financing agreements with BMO Harris and/or its affiliates, collectively (the “Lifecore Loan Agreements”):
		1)	A Credit and Security Agreement (the “Credit Agreement”) which includes (a) a one-year, $10.0 million asset-based working capital revolving line of credit, with an interest rate of LIBOR plus 1.85%, with availability based on the combination of Lifecore’s eligible accounts receivable and inventory balances (availability was $9.4 million at February 23, 2014) and with no unused fee (at February 23, 2014 and May 26, 2013, no amounts were outstanding under the line of credit) and (b) a $12.0 million term loan which matures in four years due in monthly payments of $250,000 with interest payable monthly based on a variable interest rate of LIBOR plus 2% (the “Term Loan”).
		2)	A Reimbursement Agreement pursuant to which BMO Harris caused its affiliate Bank of Montreal to issue an irrevocable letter of credit in the amount of $3.5 million (the “Letter of Credit”) which is securing the IRB described below.
	The obligations of Lifecore under the Lifecore Loan Agreements are secured by liens on all of the property of Lifecore. The Lifecore Loan Agreements contain customary covenants, such as limitations on the ability to (1) incur indebtedness or grant liens or negative pledges on Lifecore’s assets; (2) make loans or other investments; (3) pay dividends or repurchase stock or other securities; (4) sell assets; (5) engage in mergers; (6) enter into sale and leaseback transactions; (7) adopt certain benefit plans; and (8) make changes in Lifecore’s corporate structure. In addition, under the Credit Agreement, Lifecore must maintain (a) a minimum fixed charge coverage ratio of 1.10 to 1.0 and a minimum quick ratio of 1.25 to 1.00, both of which must be satisfied as of the end of each fiscal quarter commencing with the fiscal quarter ending August 26, 2012 and (b) a minimum tangible net worth of $29,000,000, measured as of May 26, 2013, and as of the end of each fiscal year thereafter. Lifecore was in compliance with all financial covenants as of February 23, 2014. Unamortized loan origination fees for the Lifecore Loan Agreements were $111,000 and $149,000 at February 23, 2014 and May 26, 2013, respectively, and are included in other assets in the Consolidated Balance Sheets. Amortization of loan origination fees recorded to interest expense for both the three months ended February 23, 2014 and February 24, 2013 was $13,000. Amortization of loan origination fees recorded to interest expense for both the nine months ended February 23, 2014 and February 24, 2013 was $39,000.
	The market value of the Company’s debt approximates its recorded value as the interest rate on each debt instrument approximates current market rates.
	The Term Loan was used to repay Lifecore’s former credit facility with Wells Fargo Bank, N.A. (“Wells Fargo”). The Letter of Credit (which replaces a letter of credit previously provided by Wells Fargo) provides liquidity
	and credit support for the IRBs.
	On August 19, 2004, Lifecore issued variable rate industrial revenue bonds (“IRBs”) which were assumed by Landec in the acquisition of Lifecore. The IRBs are collateralized by a bank letter of credit which is secured by a first mortgage on the Company’s facility in Chaska, Minnesota. In addition, the Company pays an annual remarketing fee equal to 0.125% and an annual letter of credit fee of 0.75%. The maturities on the IRBs are held in a sinking fund account, recorded in other assets in the accompanying Consolidated Balance Sheets, and are paid out each year on September 1st.

Note_11_Derivative_Financial_I

Note 11 - Derivative Financial Instruments	9 Months Ended
	Feb. 23, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Derivative Instruments and Hedging Activities Disclosure [Text Block]	'
	11.          Derivative Financial Instruments
	In May 2010, the Company entered into a five-year interest rate swap agreement which expires on April 30, 2015 under its prior credit agreement with Wells Fargo. The interest rate swap was originally designated as a cash flow hedge of future interest payments of LIBOR and had a notional amount of $20 million. As a result of the interest rate swap transaction, the Company fixed for a five-year period the interest rate at 4.24% subject to market based interest rate risk on $20 million of borrowings under the credit agreement with Wells Fargo. The Company’s obligations under the interest rate swap transaction as to the scheduled payments were guaranteed and secured on the same basis as its obligations under the credit agreement with Wells Fargo at the time the agreement was consummated. Upon entering into the new Term Loan with BMO Harris, the Company used the proceeds from that loan to pay off the Wells Fargo credit facility. The swap with Wells Fargo was not terminated upon the extinguishment of the debt with Wells Fargo. As a result of extinguishing the debt with Wells Fargo as of May 23, 2012, the swap was no longer an effective hedge and therefore, the fair value of the swap at the time the debt was extinguished of $347,000 was reversed from other comprehensive income and recorded in other expense during fiscal year 2012. The fair value of the swap arrangement as of February 23, 2014 and May 26, 2013 was $67,000 and $163,000, respectively, and is included in other accrued liabilities in the accompanying Consolidated Balance Sheets.

Note_12_Related_Party

Note 12 - Related Party	9 Months Ended
	Feb. 23, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure [Text Block]	'
	12.          Related Party
	The Company provides cooling and distribution services to both a farm and Beachside Produce LLC ("Beachside"), a commodity produce distributor, in which the Chairman of Apio has a farming and ownership interest, respectively.   During the three months ended February 23, 2014 and February 24, 2013, the Company recognized revenues of $373,000 and $334,000, respectively, which have been included in product sales and in service revenues in the accompanying Consolidated Statements of Comprehensive Income, from the sale of products and providing cooling services to these parties. During the nine months ended February 23, 2014 and February 24, 2013, the Company recognized revenues of $1.5 million and $2.0 million, respectively, which have been included in product sales and in service revenues in the accompanying Consolidated Statements of Comprehensive Income, from the sale of products and providing cooling services to these parties. The related receivable balances of $189,000 and $671,000 are included in related party accounts receivable in the accompanying Consolidated Balance Sheets as of February 23, 2014 and May 26, 2013, respectively.
	Additionally, unrelated to the revenue transactions above, the Company purchases produce from Beachside, a farm in which the Chairman of Apio has an ownership interest, and Windset for sale to third parties. During the three months ended February 23, 2014 and February 24, 2013 the Company recognized cost of product sales of $570,000 and $933,000, respectively, which have been included in cost of product sales in the accompanying Consolidated Statements of Income, from the sale of products purchased from these parties. During the nine months ended February 23, 2014 and February 24, 2013, the Company recognized cost of product sales of $3.2 million and $4.8 million, respectively, which have been included in cost of product sales in the accompanying Consolidated Statements of Income, from the sale of products purchased from these parties. The related accounts payable of $109,000 and $786,000 are included in related party accounts payable in the accompanying Consolidated Balance Sheets as of February 23, 2014 and May 26, 2013, respectively.
	All related party transactions are monitored quarterly by the Company and approved by the Audit Committee of the Board of Directors.

Note_13_Stockholders_Equity

Note 13 - Stockholders' Equity	9 Months Ended
	Feb. 23, 2014
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	13.          Stockholders’ Equity
	During the three months ended February 23, 2014, the Company did not grant any equity awards. During the nine months ended February 23, 2014, the Company granted options to purchase 291,500 shares of common stock and 128,631 of restricted stock unit awards.
	As of February 23, 2014 the Company has reserved 3.4 million shares of Common Stock for future issuance under its current and former equity plans.
	On July 14, 2010, the Company announced that the Board of Directors of the Company had approved the establishment of a stock repurchase plan which allows for the repurchase of up to $10 million of the Company’s Common Stock. The Company may repurchase its common stock from time to time in open market purchases or in privately negotiated transactions. The timing and actual number of shares repurchased is at the discretion of management of the Company and will depend on a variety of factors, including stock price, corporate and regulatory requirements, market conditions, the relative attractiveness of other capital deployment opportunities and other corporate priorities. The stock repurchase program does not obligate Landec to acquire any amount of its common stock and the program may be modified, suspended or terminated at any time at the Company's discretion without prior notice. During both the three and nine months ended February 23, 2014, the Company did not purchase any shares on the open market.
	Consolidated Statements of Changes in Stockholders’ Equity (in thousands, except share amounts):
	Common Stock Shares
	Balance at May 26, 2013		26,402,247
	Stock options exercised, net of shares tendered		339,968
	Vested restricted stock units, net of shares tendered		38,058
	Balance at February 23, 2014		26,780,273
	Common Stock
	Balance at May 26, 2013	$	26
	Stock options exercised, net of shares tendered		1
	Balance at February 23, 2014	$	27
	Additional Paid-in Capital
	Balance at May 26, 2013	$	126,258
	Stock options exercised, net of shares tendered		2,147
	Taxes incurred by Company for RSUs vested		(326	)
	Stock-based compensation expense		992
	Tax-benefit from stock based compensation expense		1,909
	Balance at February 23, 2014	$	130,980
	Retained Earnings
	Balance at May 26, 2013	$	52,409
	Net income		14,603
	Balance at February 23, 2014	$	67,012
	Non controlling Interest
	Balance at May 26, 2013	$	1,721
	Non controlling interest in net income		123
	Distributions to non controlling interest		(226	)
	Balance at February 23, 2014	$	1,618

Note_14_Business_Segment_Repor

Note 14 - Business Segment Reporting	9 Months Ended
	Feb. 23, 2014
Segment Reporting [Abstract]	'
Segment Reporting Disclosure [Text Block]	'
	14.          Business Segment Reporting
	The Company manages its business operations through three strategic business units. Based upon the information reported to the chief operating decision maker, who is the Chief Executive Officer, the Company has the following reportable segments: the Food Products Technology segment, the Food Export segment and the Hyaluronan-based Biomaterials segment.
	The Food Products Technology segment markets and packs specialty packaged whole and fresh-cut fruit and vegetables, the majority of which incorporate the BreatheWay specialty packaging for the retail grocery, club store and food services industry. In addition, the Food Products Technology segment sells BreatheWay packaging to partners for non-vegetable products. The Food Export segment consists of revenues generated from the purchase and sale of primarily whole commodity fruit and vegetable products to Asia and domestically. The HA-based Biomaterials segment sells products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, for medical use primarily in the Ophthalmic, Orthopedic and Veterinary markets. Corporate licenses Landec’s patented Intellicoat® seed coatings to the farming industry and licenses the Company’s Intelimer polymers for personal care products and other industrial products. The Corporate segment also includes general and administrative expenses, non-Food Products Technology and non HA-based Biomaterials interest income and income tax expenses. Beginning in fiscal year 2013, the Food Products Technology, the Food Export and the Hyaluronan-based Biomaterials segments include charges for corporate services and tax sharing allocated from the Corporate segment. All of the assets of the Company are located within the United States of America.
	The Company’s international sales by geography are based on the billing address of the customer and were as follows (in millions):
		Three Months Ended				Nine Months Ended
		23-Feb-14		24-Feb-13		23-Feb-14		24-Feb-13
	Taiwan	$	2.6	$	2.9	$	27.2	$	28.7
	Canada	$	12.1	$	7.4	$	31.8	$	19.7
	China	$	1.3	$	0.9	$	6.6	$	4.5
	Indonesia	$	2.2	$	4.1	$	7.1	$	17.6
	Japan	$	1.8	$	1.5	$	7.1	$	7.4
	Belgium	$	11.1	$	10.6	$	13.1	$	15.2
	All Other Countries	$	2.2	$	6.9	$	12.3	$	15.7
	Operations by segment consisted of the following (in thousands):
	Three Months Ended Febr. 23, 2014	Food Products Technology		Food Export		HA-based Biomaterials		Corporate			TOTAL
	Net sales	$	95,431	$	10,676	$	20,176	$	96		$	126,379
	International sales	$	12,013	$	10,676	$	10,613	$	—		$	33,302
	Gross profit	$	7,282	$	990	$	11,787	$	96		$	20,155
	Net income (loss)	$	131	$	206	$	7,192	$	(1,129	)	$	6,400
	Depreciation and amortization	$	1,040	$	1	$	504	$	32		$	1,577
	Dividend income	$	281	$	—	$	—	$	—		$	281
	Interest income	$	3	$	—	$	74	$	1		$	78
	Interest expense	$	332	$	—	$	58	$	—		$	390
	Income tax expense	$	468	$	58	$	2,028	$	1,125		$	3,679
	Three Months Ended Febr. 24, 2013
	Net sales	$	86,707	$	13,381	$	17,331	$	448		$	117,867
	International sales	$	7,293	$	13,381	$	13,579	$	—		$	34,253
	Gross profit	$	5,846	$	1,031	$	10,243	$	388		$	17,508
	Net income (loss)	$	338	$	228	$	5,687	$	(1,464	)	$	4,789
	Depreciation and amortization	$	1,224	$	1	$	602	$	39		$	1,866
	Dividend income	$	281	$	—	$	—				$	281
	Interest income	$	4	$	—	$	42	$	—		$	46
	Interest expense	$	421	$	—	$	66	$	—		$	487
	Income tax expense	$	113	$	76	$	1,895	$	670		$	2,754
	Nine Months Ended Febr. 23, 2014
	Net sales	$	262,957	$	55,106	$	37,539	$	282		$	355,884
	International sales	$	31,836	$	55,005	$	18,356	$	—		$	105,197
	Gross profit	$	24,383	$	4,015	$	17,800	$	223		$	46,421
	Net income (loss)	$	9,402	$	1,209	$	7,427	$	(3,435	)	$	14,603
	Depreciation and amortization	$	3,566	$	3	$	1,692	$	103		$	5,364
	Dividend income	$	844	$	—	$	—	$	—		$	844
	Interest income	$	8	$	—	$	174	$	1		$	183
	Interest expense	$	1,064	$	—	$	193	$	—		$	1,257
	Income tax expense	$	2,434	$	341	$	2,094	$	3,159		$	8,028
	Nine Months Ended Febr. 24, 2013
	Net sales	$	233,931	$	66,854	$	33,043	$	767		$	334,595
	International sales	$	19,475	$	66,747	$	22,603	$	—		$	108,825
	Gross profit	$	28,891	$	4,407	$	15,725	$	707		$	49,730
	Net income (loss)	$	15,466	$	1,403	$	5,713	$	(4,514	)	$	18,068
	Depreciation and amortization	$	3,634	$	3	$	1,777	$	113		$	5,527
	Dividend income	$	844	$	—	$	—	$	—		$	844
	Interest income	$	12	$	—	$	92	$	—		$	104
	Interest expense	$	1,303	$	—	$	223	$	—		$	1,526
	Income tax expense	$	3,846	$	467	$	1,904	$	2,021		$	8,238
	During the nine months ended February 23, 2014 and February 24, 2013, sales to the Company’s top five customers accounted for 43% and 39%, respectively, of revenues. The Company’s top two customers, Costco Wholesale Corporation and Wal-Mart Stores, Inc., from the Food Products Technology segment accounted for 20% and 12%, respectively, for nine months ended February 23, 2014 and 14% and 12%, respectively, for the nine months ended February 24, 2013. The Company expects that, for the foreseeable future, a limited number of customers may continue to account for a significant portion of its net revenues.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	9 Months Ended
	Feb. 23, 2014
Accounting Policies [Abstract]	'
Basis of Accounting, Policy [Policy Text Block]	'
	Basis of Presentation
	The accompanying unaudited consolidated financial statements of Landec have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring accruals) have been made which are necessary to present fairly the financial position at February 23, 2014 and the results of operations and cash flows for all periods presented. Although Landec believes that the disclosures in these financial statements are adequate to make the information presented not misleading, certain information normally included in financial statements and related footnotes prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted in accordance with the rules and regulations of the Securities and Exchange Commission. The accompanying financial data should be reviewed in conjunction with the audited financial statements and accompanying notes included in Landec's Annual Report on Form 10-K for the fiscal year ended May 26, 2013.
	The results of operations for the nine months ended February 23, 2014 are not necessarily indicative of the results that may be expected for an entire fiscal year because there is some seasonality in Apio’s food business, particularly, Apio’s Food Export business and the order patterns of Lifecore’s customers which may lead to significant fluctuations in Landec’s quarterly results of operations.
Consolidation, Policy [Policy Text Block]	'
	Basis of Consolidation
	The consolidated financial statements are presented on the accrual basis of accounting in accordance with U.S. generally accepted accounting principles and include the accounts of Landec Corporation and its subsidiaries, Apio and Lifecore. All material inter-company transactions and balances have been eliminated.
	Arrangements that are not controlled through voting or similar rights are reviewed under the guidance for variable interest entities (“VIEs”). A company is required to consolidate the assets, liabilities and operations of a VIE if it is determined to be the primary beneficiary of the VIE.
	An entity is a VIE and subject to consolidation, if by design: a) the total equity investment at risk is not sufficient to permit the entity to finance its activities without additional subordinated financial support provided by any parties, including equity holders or b) as a group the holders of the equity investment at risk lack any one of the following three characteristics: (i) the power, through voting rights or similar rights to direct the activities of an entity that most significantly impact the entity’s economic performance, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity. The Company reviewed the consolidation guidance and concluded that its partnership interest in Apio Cooling and its equity investments in non-public companies are not VIEs.
Use of Estimates, Policy [Policy Text Block]	'
	Use of Estimates
	The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make certain estimates and judgments that affect the amounts reported in the financial statements and accompanying notes. The accounting estimates that require management’s most significant and subjective judgments include revenue recognition; sales returns and allowances; recognition and measurement of current and deferred income tax assets and liabilities; the assessment of recoverability of long-lived assets; the valuation of intangible assets and inventory; the valuation of investments; the self-insurance liability; and the valuation and recognition of stock-based compensation.
	These estimates involve the consideration of complex factors and require management to make judgments. The analysis of historical and future trends can require extended periods of time to resolve and is subject to change from period to period. The actual results may differ from management’s estimates.
Cash and Cash Equivalents, Policy [Policy Text Block]	'
	Cash and Cash Equivalents
	The Company records all highly liquid securities with three months or less from date of purchase to maturity as cash equivalents. Cash equivalents consist mainly of certificate of deposits (CDs), money market funds and U.S. Treasuries. The market value of cash equivalents approximates their historical cost given their short-term nature.
Marketable Securities, Policy [Policy Text Block]	'
	Marketable Securities
	Short-term marketable securities consist of CDs that are FDIC insured and single A or better rated corporate and municipal bonds with original maturities of more than three months at the date of purchase regardless of the maturity date. The Company classifies all debt securities with readily determined market values as “available for sale.” The aggregate amount of CDs included in marketable securities at February 23, 2014 and May 26, 2013 was zero and $701,000, respectively. The contractual maturities of the Company’s marketable securities that are due in less than one year represented zero and $1.3 million of its marketable securities as of February 23, 2014 and May 26, 2013, respectively. The contractual maturities of the Company’s marketable securities that are due in one to two years represented zero and $251,000 of its marketable securities as of February 23, 2014 and May 26, 2013, respectively. Investments in marketable securities are carried at fair market value with unrealized gains and losses reported as other income. The cost of debt securities is adjusted for amortization of premiums and discounts to maturity. This amortization is recorded to interest income. Realized gains and losses on the sale of available-for-sale securities are also recorded to interest income. During the three and nine months ended February 23, 2014 and February 24, 2013, the Company did not sell any marketable securities. The cost of securities sold is based on the specific identification method.
Financial Instruments Policy [Policy Text Block]	'
	Financial Instruments
	The Company’s financial instruments are primarily composed of marketable securities, commercial-term trade payables, grower advances, notes receivable and debt instruments. For short-term instruments, the historical carrying amount approximates the fair value of the instrument. The fair value of long-term debt and lines of credit approximates their carrying value. Fair values for long-term financial instruments not readily marketable are estimated based upon discounted future cash flows at prevailing market interest rates. Based on these assumptions, management believes the fair market values of the Company’s financial instruments are not materially different from their recorded amounts as of February 23, 2014 and May 26, 2013.
Investment In Non-Public Companies [Policy Text Block]	'
	Investments in Non-Public Companies
	The Company’s investment in Aesthetic Sciences Corporation (“Aesthetic Sciences”), which is reported as an investment in non-public company, non-fair value, in the accompanying Consolidated Balance Sheets, is carried at cost and adjusted for impairment losses. Since there is no readily available market value information, the Company periodically reviews this investment to determine if any other than temporary declines in value have occurred based on the financial stability and viability of Aesthetic Sciences.
	On February 15, 2011, the Company made an investment in Windset Holdings 2010 Ltd., a Canadian corporation (“Windset”), which is reported as an investment in non-public company, fair value, in the accompanying Consolidated Balance Sheets as of February 23, 2014 and May 26, 2013. The Company has elected to account for its investment in Windset under the fair value option (see Note 4).
Goodwill and Intangible Assets, Policy [Policy Text Block]	'
	Intangible Assets
	The Company’s intangible assets are comprised of customer relationships with a finite estimated useful life of twelve to thirteen years and trademarks, trade names and goodwill with indefinite lives.
	Finite-lived intangible assets are reviewed for possible impairment whenever events or changes in circumstances occur that indicate that the carrying amount of an asset (or asset group) may not be recoverable.  Indefinite lived intangible assets are reviewed for impairment at least annually, in accordance with accounting guidance. For non-goodwill indefinite-lived intangible assets, the Company performs a qualitative analysis in accordance with ASC 350-30-35. For goodwill, the Company performs a quantitative analysis in accordance with ASC 350-20-35.
	During the fiscal quarter ended February 23, 2014, the Company voluntarily changed the date of its annual goodwill and indefinite-lived intangible assets impairment testing from the last day of the fiscal month in July to the first day of the fiscal fourth quarter. This voluntary change is preferable under the circumstances as it provides the Company with additional time to complete its annual goodwill and indefinite-lived intangible asset impairment testing in advance of its year-end reporting and results in better alignment with the Company’s strategic planning and forecasting process. The voluntary change in accounting principle related to the annual testing date will not delay, accelerate, or avoid an impairment charge. This change is not applied retrospectively as it is impracticable to do so because retrospective application would require application of significant estimates and assumptions with the use of hindsight. Accordingly, the change will be applied prospectively.
Self Insurance Reserve [Policy Text Block]	'
	Partial Self-Insurance on Employee Health Plan
	The Company provides health insurance benefits to eligible employees under a self-insured plan whereby the Company pays actual medical claims subject to certain stop loss limits. The Company records self-insurance liabilities based on actual claims filed and an estimate of those claims incurred but not reported. Any projection of losses concerning the Company's liability is subject to a high degree of variability. Among the causes of this variability are unpredictable external factors such as inflation rates, changes in severity, benefit level changes, medical costs, and claims settlement patterns. This self-insurance liability is included in accrued liabilities and represents management's best estimate of the amounts that have not been paid as of February 23, 2014. It is reasonably possible that the expense the Company ultimately incurs could differ and adjustments to future reserves may be necessary.
Fair Value Measurement, Policy [Policy Text Block]	'
	Fair Value Measurements
	The Company uses fair value measurement accounting for financial assets and liabilities and for financial instruments and certain other items measured at fair value. The Company has elected the fair value option for its investment in a non-public company (see Note 4). The Company has not elected the fair value option for any of its other eligible financial assets or liabilities.
	The accounting guidance established a three-tier hierarchy for fair value measurements, which prioritizes the inputs used in measuring fair value as follows:
	Level 1 – observable inputs such as quoted prices for identical instruments in active markets.
	Level 2 – inputs other than quoted prices in active markets that are observable either directly or indirectly through corroboration with observable market data.
	Level 3 – unobservable inputs in which there is little or no market data, which would require the Company to develop its own assumptions.
	As of February 23, 2014, the Company held certain assets and liabilities that are required to be measured at fair value on a recurring basis, including marketable securities, interest rate swap and a minority interest investment in Windset.
	The fair value of the Company’s marketable securities is determined based on observable inputs that are readily available in public markets or can be derived from information available in publicly quoted markets. Therefore, the Company has categorized its marketable securities as a Level 1 measurement.
	The fair value of the Company’s interest rate swap is determined based on model inputs that can be observed in a liquid market, including yield curves, and is categorized as a Level 2 measurement.
	The Company has elected the fair value option of accounting for its investment in Windset. The calculation of fair value utilizes significant unobservable inputs in the discounted cash flow models, including projected cash flows, growth rates and discount rates. As a result, the Company’s investment in Windset is considered to be a Level 3 measurement investment. The change in the fair market value of the Company’s investment in Windset for the three and nine months ended February 23, 2014 was due to the Company’s 20.1% minority interest in the change in the fair market value of Windset during those periods. In determining the fair value of the investment in Windset, the Company utilizes the following significant unobservable inputs in the discounted cash flow models:
		At February 23, 2014			At May 26, 2013
	Annual consolidated revenue growth rates		4%		3%	to	9%
	Annual consolidated expense growth rates	3%	to	4%	3%	to	8%
	Consolidated income tax rate		15%			15%
	Consolidated discount rates	16%	to	22%	18%	to	28%
	The revenue growth, expense growth and income tax rate assumptions, consider the Company's best estimate of the trends in those items over the discount period. The discount rate assumption takes into account the risk-free rate of return, the market equity risk premium and the company’s specific risk premium (collectively the “Discount rate”) and then applies an additional discount for lack of marketability of the underlying securities. The discounted cash flow valuation model used by the Company has the following sensitivity to changes in inputs and assumptions (in thousands):
			Impact on value of Windset investment as of February23, 2014
	10% increase in annual revenue growth rates		$	2,900
	10% increase in annual expense growth rates		$	(2,700	)
	10% increase in income tax rates		$	(100	)
	10% increase in discount rate		$	(1,600	)
	Imprecision in estimating unobservable market inputs can affect the amount of gain or loss recorded for a particular position. The use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.
	The following table summarizes the fair value of the Company’s assets and liabilities that are measured at fair value on a recurring basis, as of February 23, 2014 and May 26, 2013 (in thousands):
			Fair Value at February 23, 2014								Fair Value at May 26, 2013
	Assets:		Level 1				Level 2		Level 3		Level 1		Level 2		Level 3
	Marketable securities		$	-			$	-	$	-	$	1,545	$	-	$	-
	Investment in private company			-				-		37,700		-		-		29,600
	Total		$	-			$	-	$	37,700	$	1,545	$	-	$	29,600
	Liabilities:
	Interest rate swap		$	-			$	67	$	-	$	-	$	163	$	-
	Total		$	-			$	67	$	-	$	-	$	163	$	-
Revenue Recognition, Policy [Policy Text Block]	'
	Revenue Recognition
	The Company recognizes revenue when the earnings process is complete, as evidenced by an agreement with the customer, transfer of title, and acceptance, if applicable, as well as fixed pricing and probable collectability. The Company records pricing allowances, including discounts based on arrangements with customers, as a reduction to both accounts receivable and net revenue.
	When a sales arrangement contains multiple elements, the Company allocates revenue to each element based on a selling price hierarchy. The relative selling price for a deliverable is based on its vendor-specific objective evidence (VSOE), if available, third-party evidence (TPE), if VSOE is not available, or estimated selling price, if neither VSOE nor TPE is available. The Company then recognizes revenue on each deliverable in accordance with its policies for product and service revenue recognition. The Company is not typically able to determine VSOE or TPE, and therefore, uses estimated selling prices to allocate revenue between the elements of the arrangement.
	The Company limits the amount of revenue recognition for delivered elements to the amount that is not contingent on the future delivery of products or services or future performance obligations or subject to customer-specific cancellation rights. The Company evaluates each deliverable in an arrangement to determine whether they represent separate units of accounting. A deliverable constitutes a separate unit of accounting when it has stand-alone value, and for an arrangement that includes a general right of return relative to the delivered products or services, delivery or performance of the undelivered product or service is considered probable and is substantially controlled by the Company. The Company considers a deliverable to have stand-alone value if the product or service is sold separately by the Company or another vendor or could be resold by the customer. Further, the revenue arrangements generally do not include a general right of return relative to the delivered products. Where the aforementioned criteria for a separate unit of accounting are not met, the deliverable is combined with the undelivered element(s) and treated as a single unit of accounting for the purposes of allocation of the arrangement consideration and revenue recognition. The Company allocates the total arrangement consideration to each separable element of an arrangement based upon the relative selling price of each element. Allocation of the consideration is determined at arrangement inception on the basis of each unit’s relative selling price. In instances where the Company has not established fair value for any undelivered element, revenue for all elements is deferred until delivery of the final element is completed and all recognition criteria are met.
New Accounting Pronouncements, Policy [Policy Text Block]	'
	Unrecognized Tax Benefit
	In July 2013, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (a consensus of the FASB Emerging Issues Task Force) ("ASU 2013-11"), which provides that a liability related to an unrecognized tax benefit would be offset against a deferred tax asset for a net operating loss carryforward, a similar tax loss or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed. In situations in which a net operating loss carryforward, a similar tax loss or a tax credit carryforward is not available at the reporting date under the tax law of the jurisdiction or the tax law of the jurisdiction does not require, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit will be presented in the financial statements as a liability and will not be combined with deferred tax assets. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Retrospective application is permitted. ASU 2013-11 is effective for fiscal years and interim periods beginning after December 15, 2013, with early adoption permitted. The Company early adopted in the first quarter of fiscal year 2014 this standard and such adoption did not have a significant impact on the Company’s financial position or results of operations.

Note_1_Organization_Basis_of_P1

Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Feb. 23, 2014
Accounting Policies [Abstract]	'
Schedule of Effect of Significant Unobservable Inputs for Investement [Table Text Block]	'
		At February 23, 2014			At May 26, 2013
	Annual consolidated revenue growth rates		4%		3%	to	9%
	Annual consolidated expense growth rates	3%	to	4%	3%	to	8%
	Consolidated income tax rate		15%			15%
	Consolidated discount rates	16%	to	22%	18%	to	28%
Schedule of Sensitivity Analysis of Fair Value, Transferor's Interests in Transferred Financial Assets [Table Text Block]	'
			Impact on value of Windset investment as of February23, 2014
	10% increase in annual revenue growth rates		$	2,900
	10% increase in annual expense growth rates		$	(2,700	)
	10% increase in income tax rates		$	(100	)
	10% increase in discount rate		$	(1,600	)
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	'
			Fair Value at February 23, 2014								Fair Value at May 26, 2013
	Assets:		Level 1				Level 2		Level 3		Level 1		Level 2		Level 3
	Marketable securities		$	-			$	-	$	-	$	1,545	$	-	$	-
	Investment in private company			-				-		37,700		-		-		29,600
	Total		$	-			$	-	$	37,700	$	1,545	$	-	$	29,600
	Liabilities:
	Interest rate swap		$	-			$	67	$	-	$	-	$	163	$	-
	Total		$	-			$	67	$	-	$	-	$	163	$	-

Note_2_Acquisitions_of_GreenLi1

Note 2 - Acquisitions of GreenLine Holding Company (Tables)	9 Months Ended
	Feb. 23, 2014
Business Combinations [Abstract]	'
Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]	'
	Cash	$	62,900
	Contingent consideration		3,933
	Total	$	66,833
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	'
	Accounts receivable, net	$	7,057
	Inventories, net		1,409
	Property and equipment		11,669
	Other tangible assets		306
	Intangible assets		43,500
	Total identifiable assets acquired		63,941
	Accounts payable and other liabilities		(8,391	)
	Deferred taxes		(1,875	)
	Total liabilities assumed		(10,266	)
	Net identifiable assets acquired		53,675
	Goodwill		13,158
	Net assets acquired	$	66,833

Note_6_StockBased_Compensation1

Note 6 - Stock-Based Compensation (Tables)	9 Months Ended
	Feb. 23, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	'
		Three Months Ended February 23, 2014		Three Months Ended		Nine Months Ended		Nine Months Ended
				24-Feb-13		23-Feb-14		24-Feb-13
	Research and development	$	14,000	$	251,000	$	28,000	$	465,000
	Sales, general and administrative	$	339,000	$	213,000	$	964,000	$	670,000
	Total stock-based compensation	$	353,000	$	464,000	$	992,000	$	1,135,000

Note_7_Diluted_Net_Income_Per_1

Note 7 - Diluted Net Income Per Share (Tables)	9 Months Ended
	Feb. 23, 2014
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'
		Three Months Ended		Three Months Ended		Nine Months Ended		Nine Months Ended
		February 23,		February 24,		February 23,		February 24,
		2014		2013		2014		2013
	Numerator:
	Net income and comprehensive income applicable to common stockholders	$	6,400	$	4,789	$	14,603	$	18,068
	Denominator:
	Weighted average shares for basic net income per share		26,697		25,839		26,574		25,752
	Effect of dilutive securities:
	Stock options and restricted stock units		427		828		519		740
	Weighted average shares for diluted net income per share		27,124		26,667		27,093		26,492
	Diluted net income per share	$	0.24	$	0.18	$	0.54	$	0.68

Note_9_Inventories_Tables

Note 9 - Inventories (Tables)	9 Months Ended
	Feb. 23, 2014
Inventory Disclosure [Abstract]	'
Schedule of Inventory, Current [Table Text Block]	'
			23-Feb-14		26-May-13
	Finished goods	$	12,358	$	11,297
	Raw materials		10,590		9,290
	Work in progress		2,720		3,526
	Total	$	25,668	$	24,113

Note_10_Debt_Tables

Note 10 - Debt (Tables)	9 Months Ended
	Feb. 23, 2014
Debt Disclosure [Abstract]	'
Schedule of Long-term Debt Instruments [Table Text Block]	'
		23-Feb-14			26-May-13
		(in thousands)			(in thousands)
	Real estate loan agreement with General Electric Capital Corporation (“GE Capital”); due in monthly principal and interest payments of $133,060 through May 1, 2022 with interest based on a fixed rate of 4.02% per annum	$	16,373		$	17,065
	Capital equipment loan with GE Capital; due in monthly principal and interest payments of $175,356 through May 1, 2019 with interest based on a fixed rate of 4.39% per annum		9,852			11,080
	Term note with BMO Harris Bank N.A. (“BMO Harris”); due in monthly payments of $250,000 through May 23, 2016 with interest payable monthly at LIBOR plus 2% per annum		6,750			9,000
	Industrial revenue bonds (“IRBs”) issued by Lifecore; due in annual payments through 2020 with interest at a variable rate set weekly by the bond remarketing agent (0.23% and 0.38% at February 23, 2014 and May 26, 2013, respectively)		2,805			3,160
	Total		35,780			40,305
	Less current portion		(6,017	)		(5,933	)
	Long-term portion	$	29,763		$	34,372

Note_13_Stockholders_Equity_Ta

Note 13 - Stockholders' Equity (Tables)	9 Months Ended
	Feb. 23, 2014
Stockholders' Equity Note [Abstract]	'
Schedule of Stockholders Equity [Table Text Block]	'
	Common Stock Shares
	Balance at May 26, 2013		26,402,247
	Stock options exercised, net of shares tendered		339,968
	Vested restricted stock units, net of shares tendered		38,058
	Balance at February 23, 2014		26,780,273
	Common Stock
	Balance at May 26, 2013	$	26
	Stock options exercised, net of shares tendered		1
	Balance at February 23, 2014	$	27
	Additional Paid-in Capital
	Balance at May 26, 2013	$	126,258
	Stock options exercised, net of shares tendered		2,147
	Taxes incurred by Company for RSUs vested		(326	)
	Stock-based compensation expense		992
	Tax-benefit from stock based compensation expense		1,909
	Balance at February 23, 2014	$	130,980
	Retained Earnings
	Balance at May 26, 2013	$	52,409
	Net income		14,603
	Balance at February 23, 2014	$	67,012
	Non controlling Interest
	Balance at May 26, 2013	$	1,721
	Non controlling interest in net income		123
	Distributions to non controlling interest		(226	)
	Balance at February 23, 2014	$	1,618

Note_14_Business_Segment_Repor1

Note 14 - Business Segment Reporting (Tables)	9 Months Ended
	Feb. 23, 2014
Segment Reporting [Abstract]	'
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]	'
		Three Months Ended				Nine Months Ended
		23-Feb-14		24-Feb-13		23-Feb-14		24-Feb-13
	Taiwan	$	2.6	$	2.9	$	27.2	$	28.7
	Canada	$	12.1	$	7.4	$	31.8	$	19.7
	China	$	1.3	$	0.9	$	6.6	$	4.5
	Indonesia	$	2.2	$	4.1	$	7.1	$	17.6
	Japan	$	1.8	$	1.5	$	7.1	$	7.4
	Belgium	$	11.1	$	10.6	$	13.1	$	15.2
	All Other Countries	$	2.2	$	6.9	$	12.3	$	15.7
Schedule of Segment Reporting Information, by Segment [Table Text Block]	'
	Three Months Ended Febr. 23, 2014	Food Products Technology		Food Export		HA-based Biomaterials		Corporate			TOTAL
	Net sales	$	95,431	$	10,676	$	20,176	$	96		$	126,379
	International sales	$	12,013	$	10,676	$	10,613	$	—		$	33,302
	Gross profit	$	7,282	$	990	$	11,787	$	96		$	20,155
	Net income (loss)	$	131	$	206	$	7,192	$	(1,129	)	$	6,400
	Depreciation and amortization	$	1,040	$	1	$	504	$	32		$	1,577
	Dividend income	$	281	$	—	$	—	$	—		$	281
	Interest income	$	3	$	—	$	74	$	1		$	78
	Interest expense	$	332	$	—	$	58	$	—		$	390
	Income tax expense	$	468	$	58	$	2,028	$	1,125		$	3,679
	Three Months Ended Febr. 24, 2013
	Net sales	$	86,707	$	13,381	$	17,331	$	448		$	117,867
	International sales	$	7,293	$	13,381	$	13,579	$	—		$	34,253
	Gross profit	$	5,846	$	1,031	$	10,243	$	388		$	17,508
	Net income (loss)	$	338	$	228	$	5,687	$	(1,464	)	$	4,789
	Depreciation and amortization	$	1,224	$	1	$	602	$	39		$	1,866
	Dividend income	$	281	$	—	$	—				$	281
	Interest income	$	4	$	—	$	42	$	—		$	46
	Interest expense	$	421	$	—	$	66	$	—		$	487
	Income tax expense	$	113	$	76	$	1,895	$	670		$	2,754
	Nine Months Ended Febr. 23, 2014
	Net sales	$	262,957	$	55,106	$	37,539	$	282		$	355,884
	International sales	$	31,836	$	55,005	$	18,356	$	—		$	105,197
	Gross profit	$	24,383	$	4,015	$	17,800	$	223		$	46,421
	Net income (loss)	$	9,402	$	1,209	$	7,427	$	(3,435	)	$	14,603
	Depreciation and amortization	$	3,566	$	3	$	1,692	$	103		$	5,364
	Dividend income	$	844	$	—	$	—	$	—		$	844
	Interest income	$	8	$	—	$	174	$	1		$	183
	Interest expense	$	1,064	$	—	$	193	$	—		$	1,257
	Income tax expense	$	2,434	$	341	$	2,094	$	3,159		$	8,028
	Nine Months Ended Febr. 24, 2013
	Net sales	$	233,931	$	66,854	$	33,043	$	767		$	334,595
	International sales	$	19,475	$	66,747	$	22,603	$	—		$	108,825
	Gross profit	$	28,891	$	4,407	$	15,725	$	707		$	49,730
	Net income (loss)	$	15,466	$	1,403	$	5,713	$	(4,514	)	$	18,068
	Depreciation and amortization	$	3,634	$	3	$	1,777	$	113		$	5,527
	Dividend income	$	844	$	—	$	—	$	—		$	844
	Interest income	$	12	$	—	$	92	$	—		$	104
	Interest expense	$	1,303	$	—	$	223	$	—		$	1,526
	Income tax expense	$	3,846	$	467	$	1,904	$	2,021		$	8,238

Note_1_Organization_Basis_of_P2

Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) (USD $)

3 Months Ended

6 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

Feb. 23, 2014

Nov. 24, 2013

Feb. 23, 2014

26-May-13

Feb. 23, 2014

Nov. 24, 2013

Feb. 23, 2014

Nov. 24, 2013

Feb. 23, 2014

26-May-13

Feb. 23, 2014

Feb. 23, 2014

Feb. 23, 2014

Building [Member]

Building [Member]

Machinery and Equipment [Member]

Machinery and Equipment [Member]

Short Term [Member]

Short Term [Member]

Depreciable Assets [Member]

Minimum [Member]

Maximum [Member]

Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of Proprietary Platforms

2

'

2

'

'

'

'

'

'

'

'

'

'

Certificates of Deposit, at Carrying Value (in Dollars)

$0

'

$0

$701,000

'

'

'

'

'

'

'

'

'

Marketable Securities Contractual Maturity

'

'

'1 year

'

'

'

'

'

'

'

'

'1 year

'2 years

Marketable Securities (in Dollars)

0

'

0

251,000

'

'

'

'

0

1,300,000

'

'

'

Property, Plant and Equipment, Useful Life

'

'

'

'

'35 years

'29 years

'11 years

'7 years

'

'

'

'

'

NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnDepreciationExpense (in Dollars)

'

'

'

'

'

'

'

'

'

'

438,000

'

'

New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Net Income (in Dollars)

'

'

'

'

'

'

'

'

'

'

$284,000

'

'

New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Basic Earnings Per Share (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

$0.01

'

'

Finite-Lived Intangible Asset, Useful Life

'

'

'

'

'

'

'

'

'

'

'

'12 years

'13 years

Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions

20.10%

20.10%

'

'

'

'

'

'

'

'

'

'

'

Note_1_Organization_Basis_of_P3

Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) - Summary of Significant Unobservable Inputs Used in Discounted Cash Flow Models	9 Months Ended	12 Months Ended
	Feb. 23, 2014	26-May-13
Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) - Summary of Significant Unobservable Inputs Used in Discounted Cash Flow Models [Line Items]	'	'
Annual consolidated revenue growth rates	4.00%	'
Consolidated income tax rate	15.00%	15.00%
Minimum [Member]	'	'
Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) - Summary of Significant Unobservable Inputs Used in Discounted Cash Flow Models [Line Items]	'	'
Annual consolidated revenue growth rates	'	3.00%
Annual consolidated expense growth rates	3.00%	3.00%
Consolidated discount rates	16.00%	18.00%
Maximum [Member]	'	'
Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) - Summary of Significant Unobservable Inputs Used in Discounted Cash Flow Models [Line Items]	'	'
Annual consolidated revenue growth rates	'	9.00%
Annual consolidated expense growth rates	4.00%	8.00%
Consolidated discount rates	22.00%	28.00%

Note_1_Organization_Basis_of_P4

Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) - Sensitiviy to Changes in Inputs and Assumptions Used in Discounted Cash Flow Models (USD $)	Feb. 23, 2014
In Thousands, unless otherwise specified
Sensitiviy to Changes in Inputs and Assumptions Used in Discounted Cash Flow Models [Abstract]	'
10% increase in annual revenue growth rates	$2,900
10% increase in annual expense growth rates	-2,700
10% increase in income tax rates	-100
10% increase in discount rate	($1,600)

Note_1_Organization_Basis_of_P5

Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) - Summary of Fair Value of Assets and Liabilities Measure on Recurring Basis (USD $)	Feb. 23, 2014	26-May-13
In Thousands, unless otherwise specified
Fair Value, Inputs, Level 1 [Member]	'	'
Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) - Summary of Fair Value of Assets and Liabilities Measure on Recurring Basis [Line Items]	'	'
Marketable securities	'	$1,545
Total	'	1,545
Fair Value, Inputs, Level 2 [Member]	'	'
Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) - Summary of Fair Value of Assets and Liabilities Measure on Recurring Basis [Line Items]	'	'
Interest rate swap	67	163
Total	67	163
Fair Value, Inputs, Level 3 [Member]	'	'
Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details) - Summary of Fair Value of Assets and Liabilities Measure on Recurring Basis [Line Items]	'	'
Investment in private company	37,700	29,600
Total	$37,700	$29,600

Note_2_Acquisitions_of_GreenLi2

Note 2 - Acquisitions of GreenLine Holding Company (Details) (USD $)	0 Months Ended	9 Months Ended				9 Months Ended	0 Months Ended	9 Months Ended
	Aug. 23, 2012	Feb. 23, 2014	Feb. 24, 2013	26-May-13	Apr. 23, 2012	Feb. 23, 2014	Apr. 23, 2012	Feb. 23, 2014
						GreenLine [Member]	GreenLine [Member]	GreenLine [Member]
						Customer Base [Member]
Note 2 - Acquisitions of GreenLine Holding Company (Details) [Line Items]	'	'	'	'	'	'	'	'
Number of Processing Plants	'	'	'	'	'	'	4	'
Business Combination, Consideration Transferred	$66,833,000	'	'	'	'	'	$66,800,000	'
Effective Income Tax Rate Reconciliation, Percent	'	35.00%	31.00%	'	'	'	'	40.00%
Number of Intangible Assets Identified	'	'	'	'	'	'	'	2
Indefinite Lived Intangible Assets Market Value	'	'	'	'	'	'	'	36,000,000
Finite-lived Intangible Assets Acquired	'	'	'	'	'	7,500,000	'	'
Finite-Lived Intangible Asset, Useful Life	'	'	'	'	'	'13 years	'	'
Goodwill	'	$49,620,000	'	$49,620,000	$13,158,000	'	'	$13,200,000

Note_2_Acquisitions_of_GreenLi3

Note 2 - Acquisitions of GreenLine Holding Company (Details) - Acquisition Date Fair Value of Total Consideration Transferred (USD $)	0 Months Ended
In Thousands, unless otherwise specified	Aug. 23, 2012
Acquisition Date Fair Value of Total Consideration Transferred [Abstract]	'
Cash	$62,900
Contingent consideration	3,933
Total	$66,833

Note_2_Acquisitions_of_GreenLi4

Note 2 - Acquisitions of GreenLine Holding Company (Details) - Summary of the Estimated Fair Values of GreenLines Assets Acquired and Liabilities Assumed (USD $)	Feb. 23, 2014	26-May-13	Apr. 23, 2012
In Thousands, unless otherwise specified
Summary of the Estimated Fair Values of GreenLines Assets Acquired and Liabilities Assumed [Abstract]	'	'	'
Accounts receivable, net	'	'	$7,057
Inventories, net	'	'	1,409
Property and equipment	'	'	11,669
Other tangible assets	'	'	306
Intangible assets	'	'	43,500
Total identifiable assets acquired	'	'	63,941
Accounts payable and other liabilities	'	'	-8,391
Deferred taxes	'	'	-1,875
Total liabilities assumed	'	'	-10,266
Net identifiable assets acquired	'	'	53,675
Goodwill	49,620	49,620	13,158
Net assets acquired	'	'	$66,833

Note_3_Sale_of_Landec_Ag_Detai

Note 3 - Sale of Landec Ag (Details) (USD $)	0 Months Ended	3 Months Ended
	Jun. 24, 2012	Aug. 25, 2013
Note 3 - Sale of Landec Ag (Details) [Line Items]	'	'
Number of Licensing Agreements	2	'
Landec Ag LLC [Member]	'	'
Note 3 - Sale of Landec Ag (Details) [Line Items]	'	'
Proceeds from Divestiture of Businesses, Net of Cash Divested	$600,000	'
Gain (Loss) on Disposition of Business	400,000	'
Disposal Group, Deferred Gain on Disposal	300,000	'
Amortization Period Of Deferred Gain Loss On Divestiture Of Investment	'7 years	'
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal	'	$100,000

Note_4_Investments_in_Nonpubli1

Note 4 - Investments in Non-public Companies (Details) (USD $)

3 Months Ended

9 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

Feb. 23, 2014

Feb. 24, 2013

Feb. 23, 2014

Feb. 23, 2014

Feb. 24, 2013

Feb. 15, 2011

Feb. 15, 2011

Feb. 15, 2011

30-May-10

26-May-13

Feb. 23, 2013

Jul. 16, 2010

Feb. 15, 2011

31-May-13

31-May-12

Feb. 23, 2014

Feb. 24, 2013

Feb. 23, 2014

Feb. 24, 2013

Preferred Stock [Member]

Common Stock [Member]

Common Stock [Member]

Aesthetic Sciences [Member]

Aesthetic Sciences [Member]

Aesthetic Sciences [Member]

Aesthetic Sciences [Member]

Windset [Member]

Windset [Member]

Windset [Member]

Windset [Member]

Windset [Member]

Windset [Member]

Windset [Member]

Windset [Member]

Apio [Member]

Windset [Member]

Windset [Member]

Note 4 - Investments in Non-public Companies (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term Investments

'

'

'

'

'

'

'

'

'

$793,000

$793,000

$1,800,000

'

'

'

'

'

'

'

Other than Temporary Impairment Losses, Investments

'

'

'

'

'

'

'

'

1,000,000

'

'

'

'

'

'

'

'

'

'

Investment in Non-Public Company Shares (in Shares)

'

'

'

'

'

150,000

201

'

'

'

'

'

'

'

'

'

'

'

'

Payments to Acquire Investments

'

'

'

'

'

'

201

15,000,000

'

'

'

'

'

'

'

'

'

'

'

Investment Ownership Percentage

'

'

'

'

'

'

'

'

'

'

'

'

20.10%

'

'

'

'

'

'

Preferred Stock, Dividend Rate, Percentage

'

'

'

'

'

'

'

'

'

'

'

'

7.50%

'

'

'

'

'

'

Dividends and Interest Paid

'

'

'

'

'

'

'

'

'

'

'

'

'

1.1

1,100,000

'

'

'

'

Investment Income, Dividend

281,000

281,000

844,000

844,000

844,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Change in Market Value Of Investment in Company

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$400,000

$1,000,000

$8,100,000

$6,300,000

Note_5_Collaborative_Agreement1

Note 5 - Collaborative Agreements (Details) (USD $)	0 Months Ended		1 Months Ended	0 Months Ended	1 Months Ended
	Jun. 24, 2012	Jun. 24, 2012	Jun. 30, 2010	Jun. 24, 2012	Mar. 31, 2006
	First Four Years [Member]	Last Three Years [Member]	Apio [Member]	INCOTEC [Member]	Air Products [Member]
	INCOTEC [Member]	INCOTEC [Member]	Windset [Member]
Note 5 - Collaborative Agreements (Details) [Line Items]	'	'	'	'	'
License Agreement Term	'	'	'	'7 years	'
Royalty Percentage	20.00%	10.00%	'	'	'
License Agreement Profit Percentage	'	'	'	'	40.00%
Development Fee (in Dollars)	'	'	$100,000	'	'
Annual License Fee Percentage	'	'	3.00%	'	'
Annual Minimum License Fees (in Dollars)	'	'	$150,000	'	'

Note_6_StockBased_Compensation2

Note 6 - Stock-Based Compensation (Details) (USD $)	3 Months Ended		9 Months Ended
	Feb. 23, 2014	Feb. 24, 2013	Feb. 23, 2014	Feb. 24, 2013
Note 6 - Stock-Based Compensation (Details) [Line Items]	'	'	'	'
Share-based Compensation	$353,000	$464,000	$992,000	$1,135,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	2,400,000	'	2,400,000	'
Restricted Stock Units (RSUs) [Member]	'	'	'	'
Note 6 - Stock-Based Compensation (Details) [Line Items]	'	'	'	'
Share-based Compensation	222,000	230,000	576,000	528,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	'	'	'2 years	'
Employee Stock Option [Member]	'	'	'	'
Note 6 - Stock-Based Compensation (Details) [Line Items]	'	'	'	'
Share-based Compensation	$131,000	$234,000	$416,000	$607,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	'	'	'2 years 36 days	'

Note_6_StockBased_Compensation3

Note 6 - Stock-Based Compensation (Details) - Summary of Stock-Based Compensation by Income Statement Line Item (USD $)	3 Months Ended		9 Months Ended
	Feb. 23, 2014	Feb. 24, 2013	Feb. 23, 2014	Feb. 24, 2013
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Allocated stock-based compensation	$353,000	$464,000	$992,000	$1,135,000
Research and Development Expense [Member]	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Allocated stock-based compensation	14,000	251,000	28,000	465,000
Sales, General and Administrative [Member]	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Allocated stock-based compensation	$339,000	$213,000	$964,000	$670,000

Note_7_Diluted_Net_Income_Per_2

Note 7 - Diluted Net Income Per Share (Details)	3 Months Ended		9 Months Ended
	Feb. 23, 2014	Feb. 24, 2013	Feb. 23, 2014	Feb. 24, 2013
Earnings Per Share [Abstract]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	342,500	95,527	332,037	88,128

Note_7_Diluted_Net_Income_Per_3

Note 7 - Diluted Net Income Per Share (Details) - Diluted Net Income Per Share (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Feb. 23, 2014	Feb. 24, 2013	Feb. 23, 2014	Feb. 24, 2013
Diluted Net Income Per Share [Abstract]	'	'	'	'
Net income and comprehensive income applicable to common stockholders (in Dollars)	$6,400	$4,789	$14,603	$18,068
Weighted average shares for basic net income per share	26,697	25,839	26,574	25,752
Stock options and restricted stock units	427	828	519	740
Weighted average shares for diluted net income per share	27,124	26,667	27,093	26,492
Diluted net income per share (in Dollars per share)	$0.24	$0.18	$0.54	$0.68

Note_8_Income_Taxes_Details

Note 8 - Income Taxes (Details) (USD $)	3 Months Ended		9 Months Ended
	Feb. 23, 2014	Feb. 24, 2013	Feb. 23, 2014	Feb. 24, 2013	26-May-13
Income Tax Disclosure [Abstract]	'	'	'	'	'
Income Tax Expense (Benefit)	$3,679,000	$2,754,000	$8,028,000	$8,238,000	'
Effective Income Tax Rate Reconciliation, Percent	'	'	35.00%	31.00%	'
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	'	'	35.00%	'	'
Unrecognized Tax Benefits	1,000,000	'	1,000,000	'	1
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	$827,000	'	$827,000	'	$807,000

Note_9_Inventories_Details_Inv

Note 9 - Inventories (Details) - Inventories (USD $)	Feb. 23, 2014	26-May-13
In Thousands, unless otherwise specified
Inventories [Abstract]	'	'
Finished goods	$12,358	$11,297
Raw materials	10,590	9,290
Work in progress	2,720	3,526
Total	$25,668	$24,113

Note_10_Debt_Details

Note 10 - Debt (Details) (USD $)

Feb. 23, 2014

26-May-13

23-May-12

Feb. 23, 2014

Feb. 24, 2013

Feb. 23, 2014

Feb. 24, 2013

Feb. 23, 2014

26-May-13

Apr. 23, 2012

Feb. 23, 2014

26-May-13

Feb. 23, 2014

Feb. 23, 2014

Feb. 23, 2014

Aug. 26, 2012

Feb. 23, 2014

26-May-13

Feb. 23, 2014

Feb. 23, 2014

Feb. 23, 2014

23-May-12

Feb. 23, 2014

26-May-13

23-May-12

GE [Member]

GE [Member]

GE [Member]

GE [Member]

GE [Member]

GE [Member]

Apio [Member]

Apio [Member]

Apio [Member]

Apio [Member]

Lifecore [Member]

Lifecore [Member]

Lifecore [Member]

Lifecore [Member]

Lifecore [Member]

Remarketing Fee [Member]

Annual Fees [Member]

Term Loan [Member]

Working Capital Line of Credit [Member]

Working Capital Line of Credit [Member]

Working Capital Line of Credit [Member]

Term Loan [Member]

Amortization of Loan Origination Fees [Member]

Amortization of Loan Origination Fees [Member]

Amortization of Loan Origination Fees [Member]

Amortization of Loan Origination Fees [Member]

Amortization of Loan Origination Fees [Member]

Amortization of Loan Origination Fees [Member]

Note 10 - Debt (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility Term

'

'

'

'

'

'

'

'

'

'5 years

'

'

'

'

'

'

'

'

'

'

'

'1 year

'

'

'

Line of Credit Facility, Maximum Borrowing Capacity

'

'

'

'

'

'

'

'

'

$25,000,000

'

'

'

'

'

'

'

'

'

'

'

$10,000,000

'

'

'

Debt Instrument, Basis Spread on Variable Rate

'

'

'

'

'

'

'

'

'

2.00%

'

'

'

'

'

'

'

'

'

'

'

1.85%

'

'

2.00%

Line of Credit Facility, Remaining Borrowing Capacity

'

'

'

'

'

'

'

'

'

'

19,200,000

'

'

'

'

'

'

'

'

'

'

'

9,400,000

'

'

Line of Credit Facility, Unused Capacity, Commitment Fee Percentage

'

'

'

'

'

'

'

'

'

0.38%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Amount Outstanding

'

'

'

'

'

'

'

'

'

'

0

4,000,000

'

'

'

'

'

'

'

'

'

'

0

0

'

Minimum Fixed Charge Coverage Ratio

'

'

'

'

'

'

'

'

'

'

'

'

1.1

'

'

'

1.1

'

'

'

'

'

'

'

'

Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums

'

'

'

'

'

'

'

1,000,000

1,200,000

'

'

'

'

'

'

'

111,000

149,000

'

'

'

'

'

'

'

Interest Expense, Other

'

'

'

47,000

45,000

140,000

136,000

'

'

'

'

'

'

13,000

39,000

'

'

'

'

'

'

'

'

'

'

Number of Financing Agreements

'

'

2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Minimum Quick Ratio

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'1) A Credit and Security Agreement (the "Credit Agreement") which includes (a) a one-year, $10.0 million asset-based working capital revolving line of credit, with an interest rate of LIBOR plus 1.85%, with availability based on the combination of Lifecore's eligible accounts receivable and inventory balances (availability was $9.4 million at February 23, 2014) and with no unused fee (at February 23, 2014 and May 26, 2013, no amounts were outstanding under the line of credit) and (b) a $12.0 million term loan which matures in four years due in monthly payments of $250,000 with interest payable monthly based on a variable interest rate of LIBOR plus 2% (the "Term Loan").

'1.25

'

'

'

'

'

'

'

'

Line of Credit Facility, Commitment Fee Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

'

'

Long-term Debt

35,780,000

40,305,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

12,000,000

'

'

'

'

Long Term Debt Contractual Maturity Term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'4 years

Debt Instrument, Periodic Payment, Principal

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

250,000

Letters of Credit Outstanding, Amount

'

'

3,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Minimum Tangible Net Worth

'

$29,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Annual Re-Marketing Fee Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.13%

'

'

'

'

'

'

Annual Letter of Credit Fee Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.75%

'

'

'

'

'

Note_10_Debt_Details_Longterm_

Note 10 - Debt (Details) - Long-term Debt (USD $)	Feb. 23, 2014	26-May-13
In Thousands, unless otherwise specified
Debt Instrument [Line Items]	'	'
Debt balance	$35,780	$40,305
Less current portion	-6,017	-5,933
Long-term portion	29,763	34,372
Real Estate Loan [Member]	'	'
Debt Instrument [Line Items]	'	'
Debt balance	16,373	17,065
Capital Equipment Loan [Member]	'	'
Debt Instrument [Line Items]	'	'
Debt balance	9,852	11,080
Term Note [Member]	'	'
Debt Instrument [Line Items]	'	'
Debt balance	6,750	9,000
Industrial Revenue Bonds [Member]	'	'
Debt Instrument [Line Items]	'	'
Debt balance	$2,805	$3,160

Note_10_Debt_Details_Longterm_1

Note 10 - Debt (Details) - Long-term Debt (Parentheticals) (USD $)	9 Months Ended	12 Months Ended
	Feb. 23, 2014	26-May-13
Real Estate Loan [Member]	'	'
Debt Instrument [Line Items]	'	'
Monthly payment principal and interest (in Dollars)	$133,060,000	$133,060,000
Annual fixed interest rate	4.02%	4.02%
Capital Equipment Loan [Member]	'	'
Debt Instrument [Line Items]	'	'
Monthly payment principal and interest (in Dollars)	175,356,000	175,356,000
Annual fixed interest rate	4.39%	4.39%
Term Note [Member]	'	'
Debt Instrument [Line Items]	'	'
Term note with BMO Harris monthly payments (in Dollars)	$250,000,000	$250,000,000
Variable interest rate	2.00%	2.00%
Industrial Revenue Bonds [Member]	'	'
Debt Instrument [Line Items]	'	'
Variable interest rate	0.23%	0.38%

Note_11_Derivative_Financial_I1

Note 11 - Derivative Financial Instruments (Details) (USD $)	0 Months Ended				1 Months Ended
	23-May-12	Feb. 23, 2014	26-May-13	30-May-10	30-May-10
					Wells Fargo [Member]
Note 11 - Derivative Financial Instruments (Details) [Line Items]	'	'	'	'	'
Derivative Asset, Notional Amount	'	'	'	$20,000,000	'
Interest Rate Swap Term	'	'	'	'	'5 years
Derivative, Swaption Interest Rate	'	'	'	4.24%	'
Derivative, Notional Amount	'	'	'	20,000,000	'
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	347,000	'	'	'	'
Derivative Liability, Fair Value, Gross Liability	'	$67,000	$163,000	'	'

Note_12_Related_Party_Details

Note 12 - Related Party (Details) (USD $)	3 Months Ended		9 Months Ended
	Feb. 23, 2014	Feb. 24, 2013	Feb. 23, 2014	Feb. 24, 2013	26-May-13
Note 12 - Related Party (Details) [Line Items]	'	'	'	'	'
Revenue from Related Parties	$350,000	$283,000	$1,375,000	$1,618,000	'
Related Party Transaction, Due from (to) Related Party	189,000	'	189,000	'	671,000
Related Party Transaction, Purchases from Related Party	570,000	933,000	3,200,000	4,800,000	'
Accounts Payable, Related Parties	109,000	'	109,000	'	786,000
Beachside [Member]	'	'	'	'	'
Note 12 - Related Party (Details) [Line Items]	'	'	'	'	'
Revenue from Related Parties	$373,000	$334,000	$1,500,000	$2,000,000	'

Note_13_Stockholders_Equity_De

Note 13 - Stockholders' Equity (Details) (USD $)	0 Months Ended	3 Months Ended	6 Months Ended	9 Months Ended
In Millions, except Share data, unless otherwise specified	Jul. 14, 2010	Feb. 23, 2014	Nov. 24, 2013	Feb. 23, 2014
Note 13 - Stockholders' Equity (Details) [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	'	0	'	291,500
Common Stock, Capital Shares Reserved for Future Issuance	'	3,400,000	'	3,400,000
Stock Repurchase Program, Authorized Amount (in Dollars)	$10	'	'	'
Stock Repurchased During Period, Shares	'	0	0	'
Restricted Stock Units (RSUs) [Member]	'	'	'	'
Note 13 - Stockholders' Equity (Details) [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	'	'	'	128,631

Note_13_Stockholders_Equity_De1

Note 13 - Stockholders' Equity (Details) - Consolidated Statements of Changes in Stockholders' Equity (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Feb. 23, 2014	Feb. 24, 2013	Feb. 23, 2014	Feb. 24, 2013
Common Stock Shares	'	'	'	'
Balance, Common Stock Shares (in Shares)	'	'	26,402,247	'
Stock options exercised, net of shares tendered (in Shares)	'	'	339,968	'
Vested restricted stock units, net of shares tendered (in Shares)	'	'	38,058	'
Balance, Common Stock Shares (in Shares)	26,780,273	'	26,780,273	'
Common Stock	'	'	'	'
Balance, Common Stock	'	'	$26	'
Stock options exercised, net of shares tendered	'	'	1	'
Balance, Common Stock	27	'	27	'
Additional Paid-in Capital	'	'	'	'
Balance, Additional Paid-in Capital	'	'	126,258	'
Stock options exercised, net of shares tendered	'	'	2,147	'
Taxes incurred by Company for RSUs vested	'	'	-326	'
Stock-based compensation expense	'	'	992	'
Tax-benefit from stock based compensation expense	'	'	1,909	'
Balance, Additional Paid-in Capital	130,980	'	130,980	'
Retained Earnings	'	'	'	'
Balance, Retained Earnings	'	'	52,409	'
Net income	6,400	4,789	14,603	18,068
Balance, Retained Earnings	67,012	'	67,012	'
Non controlling Interest	'	'	'	'
Balance, Non Controlling Interest	'	'	1,721	'
Non controlling interest in net income	22	3	123	159
Distributions to non controlling interest	'	'	-226	-320
Balance, Non Controlling Interest	$1,618	'	$1,618	'

Note_14_Business_Segment_Repor2

Note 14 - Business Segment Reporting (Details)	9 Months Ended
	Feb. 23, 2014	Feb. 24, 2013
Note 14 - Business Segment Reporting (Details) [Line Items]	'	'
Number of Operating Segments	3	'
Customer 1 [Member] | Food Products Technology [Member] | Customer Concentration Risk [Member] | Sales Revenue, Net [Member]	'	'
Note 14 - Business Segment Reporting (Details) [Line Items]	'	'
Concentration Risk, Percentage	20.00%	14.00%
Customer 2 [Member] | Food Products Technology [Member] | Customer Concentration Risk [Member] | Sales Revenue, Net [Member]	'	'
Note 14 - Business Segment Reporting (Details) [Line Items]	'	'
Concentration Risk, Percentage	'	12.00%
Food Products Technology [Member] | Customer Concentration Risk [Member] | Sales Revenue, Net [Member]	'	'
Note 14 - Business Segment Reporting (Details) [Line Items]	'	'
Entity-Wide Revenue Major Customer Number	2	2
Concentration Risk, Percentage	'	12.00%
Customer Concentration Risk [Member] | Sales Revenue, Net [Member]	'	'
Note 14 - Business Segment Reporting (Details) [Line Items]	'	'
Entity-Wide Revenue Major Customer Number	5	5
Concentration Risk, Percentage	43.00%	39.00%

Note_14_Business_Segment_Repor3

Note 14 - Business Segment Reporting (Details) - Sales by Geograhic Area (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Feb. 23, 2014	Feb. 24, 2013	Feb. 23, 2014	Feb. 24, 2013
Note 14 - Business Segment Reporting (Details) - Sales by Geograhic Area [Line Items]	'	'	'	'
Segment sales	$126,379	$117,867	$355,884	$334,595
TAIWAN, PROVINCE OF CHINA	'	'	'	'
Note 14 - Business Segment Reporting (Details) - Sales by Geograhic Area [Line Items]	'	'	'	'
Segment sales	2,600	2,900	27,200	28,700
CANADA	'	'	'	'
Note 14 - Business Segment Reporting (Details) - Sales by Geograhic Area [Line Items]	'	'	'	'
Segment sales	12,100	7,400	31,800	19,700
CHINA	'	'	'	'
Note 14 - Business Segment Reporting (Details) - Sales by Geograhic Area [Line Items]	'	'	'	'
Segment sales	1,300	900	6,600	4,500
INDONESIA	'	'	'	'
Note 14 - Business Segment Reporting (Details) - Sales by Geograhic Area [Line Items]	'	'	'	'
Segment sales	2,200	4,100	7,100	17,600
JAPAN	'	'	'	'
Note 14 - Business Segment Reporting (Details) - Sales by Geograhic Area [Line Items]	'	'	'	'
Segment sales	1,800	1,500	7,100	7,400
BELGIUM	'	'	'	'
Note 14 - Business Segment Reporting (Details) - Sales by Geograhic Area [Line Items]	'	'	'	'
Segment sales	11,100	10,600	13,100	15,200
All Other Countries [Member]	'	'	'	'
Note 14 - Business Segment Reporting (Details) - Sales by Geograhic Area [Line Items]	'	'	'	'
Segment sales	$2,200	$6,900	$12,300	$15,700

Note_14_Business_Segment_Repor4

Note 14 - Business Segment Reporting (Details) - Operations by Business Segment (USD $)	3 Months Ended		9 Months Ended
	Feb. 23, 2014	Feb. 24, 2013	Feb. 23, 2014	Feb. 23, 2014	Feb. 24, 2013
Segment Reporting Information [Line Items]	'	'	'	'	'
Net sales	$126,379,000	$117,867,000	$355,884,000	'	$334,595,000
International sales	33,302,000	34,253,000	105,197,000	'	108,825,000
Gross profit	20,155,000	17,508,000	46,421,000	'	49,730,000
Net income (loss)	6,400,000	4,789,000	14,603,000	'	18,068,000
Depreciation and amortization	1,577,000	1,866,000	5,364,000	'	5,527,000
Dividend Income	281,000	281,000	844,000	844,000	844,000
Interest income	78,000	46,000	183,000	'	104,000
Interest expense	390,000	487,000	1,257,000	'	1,526,000
Income tax expense	3,679,000	2,754,000	8,028,000	'	8,238,000
Food Products Technology [Member]	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Net sales	95,431,000	86,707,000	262,957,000	'	233,931,000
International sales	12,013,000	7,293,000	31,836,000	'	19,475,000
Gross profit	7,282,000	5,846,000	24,383,000	'	28,891,000
Net income (loss)	131,000	338,000	9,402,000	'	15,466,000
Depreciation and amortization	1,040,000	1,224,000	3,566,000	'	3,634,000
Dividend Income	281,000	281,000	844,000	'	844,000
Interest income	3,000	4,000	8,000	'	12,000
Interest expense	332,000	421,000	1,064,000	'	1,303,000
Income tax expense	468,000	113,000	2,434,000	'	3,846,000
Food Export [Member]	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Net sales	10,676,000	13,381,000	55,106,000	'	66,854,000
International sales	10,676,000	13,381,000	55,005,000	'	66,747,000
Gross profit	990,000	1,031,000	4,015,000	'	4,407,000
Net income (loss)	206,000	228,000	1,209,000	'	1,403,000
Depreciation and amortization	1,000	1,000	3,000	'	3,000
Income tax expense	58,000	76,000	341,000	'	467,000
HA-based Biomaterials [Member]	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Net sales	20,176,000	17,331,000	37,539,000	'	33,043,000
International sales	10,613,000	13,579,000	18,356,000	'	22,603,000
Gross profit	11,787,000	10,243,000	17,800,000	'	15,725,000
Net income (loss)	7,192,000	5,687,000	7,427,000	'	5,713,000
Depreciation and amortization	504,000	602,000	1,692,000	'	1,777,000
Interest income	74,000	42,000	174,000	'	92,000
Interest expense	58,000	66,000	193,000	'	223,000
Income tax expense	2,028,000	1,895,000	2,094,000	'	1,904,000
Corporate Segment [Member]	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Net sales	96,000	448,000	282,000	'	767,000
Gross profit	96,000	388,000	223,000	'	707,000
Net income (loss)	-1,129,000	-1,464,000	-3,435,000	'	-4,514,000
Depreciation and amortization	32,000	39,000	103,000	'	113,000
Interest income	1,000	'	1,000	'	'
Income tax expense	$1,125,000	$670,000	$3,159,000	'	$2,021,000